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CHAPTER 1 
INTRODUCTION 
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INTERFERON-INDUCED GENE EXPRESSION 
1.1.1 Introduction 
Interferons (lFNs) were discovered over 30 years ago by Isaacs and Lindenmann 
(1957), who observed that supernatants from virus-infected cell cultures contained a 
protein that could react with cells to render them resistant to infection by many viruses. 
Since then much has been learned about the IFN system, including its defensive role in 
vivo and applicability to treatment of disease (Pestka, 1986a; Baron et aI., 1987; Dianzani 
and Antonelli, 1989; Nelson and Borden, 1989; Taylor and Grossberg, 1990). Although 
IFNs were first recognized for their potent antiviral properties, it has now been established 
that they may profoundly affect other vital cellular and body functions, including 
anti proliferative, antitumor, immunomodulatory and hormonal actions (Pestka, 1986a; 
Baron et aI., 1987; Dianzani and Antonelli, 1989; Nelson and Borden, 1989; Taylor and 
Grossberg, 1990). Clinically, IFN treatment proved to be beni!icial in the case of numerous 
human diseases including viral infections and cancer (Baron at al.. 1991). 
IFNs are a family of molecules which can be divided into three species: IFN-a, IFN-P, 
and IFN-y. IFN-a and IFN-P are also known as Type IIFNs, IFN-y as Type IIIFN. Type IIFNs 
can be produced by many cell types and induced by many substances, but the amount 
produced and the subspecies induced can vary per cell type and per inducer. Viruses and 
synthetic double stranded RNAs are amongst the best inducers. Type II IFN is largely 
produced by T lymphocytes stimulated by foreign antigens or mitogens (Baron et aI., 
1991 ). 
In all mammalian species studied to date, the a IFNs are encoded by a family of 
closely related genes (Weissman and Weber, 1986). In man there are at least 14 
"classical" IFN-a genes (lFNA) (Diaz, 1993) and 4 pseudogenes (lFNP). clustered on the 
short arm of chromosome 9 (Trent et al .. 1982; Henco et al .. 1985; Olopade et aI., 1992). 
The human IFN-a genes exhibit a high degree of, sequence homology, ranging from 80 to 
, 
almost 100% within their coding regions. An additional, IFNA-related member of the 
human IFN-a superfamily has been identified: IFN-w1 (W1) (previously designated IFN-a 
class 11-1), which exhibits approximately 70% sequence homology with the other human 
IFN-a genes (Capon et al .. 1985; Hauptmann and Swetly, 1985). Seven closely related, 
albeit non functional, human IFN-W pseudogenes (lFNWP) have also been described 
(Feinstein et aI., 1985; Weissman and Weber, 1986; De Maeyer and De Maeyer-Guignard, 
1988; Diaz, 1993). Multiple functionallFN-W genes have been described in caUle, horses, 
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and sheep (Capon et aI., 1985; Himmler et al" 1986; Adolf et al" 1991). In contrast, the 
IFN-W genes appear to be absent in dogs and mice (Himmler et al., 1987; De Maeyer and 
De Maeyer-Guignard, 1988). 
Human IFN-P (or IFN-8) (Diaz, 1993) is encoded by a single copy gene, which 
exhibits approximately 50% homology at the nucleotide level to the IFN-a genes, and 
which is physically closely associated with the IFN-a gene family. The mouse, in common 
with man, possesses a single IFN-P gene, whereas cattie, sheep, and pigs possess multiple 
IFN-P genes (Weissman and Weber, 1986; De Maeyer and De Maeyer-Guignard, 1988). 
In human, type I IFN genes UFN-A, oW, and -8) are located within the band p22 on 
the short arm of chromosome 9 (Trent et aI., 1982; Olopade et aI., 1992). Recently, the 
first complete physical map of the type IIFN gene cluster has been established (Diaz et aI., 
1991; Olopade et aI., 1992). 
In all animal species studied, type I IFN genes arB devoid of introns and encode 
proteins of 186 to 190 amino acids, including a signal peptide of 23 amino acids (Pestka 
et al" 1987; De Maeyer and De Maeyer-Guignard, 1988). It is assumed that type I IFN 
genes share a common ancestor and that the IFN-a gene family arose by repeated 
duplications of the ancestral a gene. The IFN-a genes are relatively well conserved. Within 
a species the homology between the proteins is 70% or more. Between human and murine 
IFN-a proteins the homology is 50 to 60%. Despite these structural similarities, lFNas are 
relatively species-specific: most human IFNs have only a low activity on mouse cells (Week 
et al" 1981). However, certain mouse IFNas reveal high antiviral activity on hamster cells 
(Van Heuvel et aI., 1986). Human IFN-y is encoded by a single gene, which contains three 
introns, and which is located on the long arm of chromosome 12 (Kellye et al" 1983; 
Lovett et aI., 1984). Type IIIFNs contain approx. 146 amino acids and show no significant 
sequence homology with type I IFNs (Gray et al" 1982; Trent et al" 1982; Pestka et al., 
1987). All other animal species studied to date: including the mouse, cattie, sheep, and 
pig, also possess a single IFN-y gene. 
Sheep, cattie, and other ruminants possess a distinct class of genes which code for 
the throphoblast IFNs. These are proteins which are secreted by throphoblasts during eafly 
pregnancy and which regulate maternal recognition of pregnancy (Cross and Roberts. 
1991). In addition, the throphoblast IFNs exhibit antiviral activity in common with other 
IFNs, and are able to bind the same receptor as IFN-a, IFN-P and IFN-w (Stewart et aI., 
1987). 
To elicit their biological properties, it is necessary that the IFNs bind to specific 
receptors on the target cells. The interaction of IFNs with their cognate receptors activates 
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cytoplasmic signals that enter the nucleus to stimulate the induction of a set of primary 
genes which are central in mediating the biological response. This transcriptional activation 
is rapid and does not require protein synthesis (Levy and Darnell, 1990a; Williams, 1991; 
Sen and Lengyel, 1992; Pellegrini and Schindler, 1993). The delayed activation of other 
genes is also part of this response, however, pathway(s) that activate late genes are likely 
to be indirect, less specific and are not yet well understood. Similar genetic activation of 
cells by IFN appears to be required for most of its biological actions, e.g. antiviral, cell 
growth inhibitory and immunomodulatory activities. 
1.1.2 The IFN·aIO and IFN-y signalling pathways (Model for polypeptide-dependent gene 
activation) 
Initiation of the signal transduction pathway occurs when IFNs interact with their 
cognate receptors. Receptor occupancy rapidly triggers signalling cascades through the 
activation of tyrosine kinases which culminate in the activation (by tyrosine 
phosphorylation) of cytoplasmic signalling proteins. Once activated, a ligand-specific set 
of cytosolic proteins transduce the signal to the appropriate DNA target sequences in the 
nucleus (Levy and Darnell, 1990a; Pellegrini and Schindler, 1993). 
The IFN·alp and IFN-Y signalling pathways serve as models for cell receptors whose 
occupation ultimately stimulates transcription through a DNA-binding protein that 
recognizes a specific consensus element in the DNA, via a specific cytoplasmic counterpart 
(receptor-recognition protein). The pathway that would conserve specificity includes at 
least four highly specific reactions: (I) the ligan?-receptor interaction; (II) the recognition 
of the intracellular domain of the receptor by a cytoplasmic protein capable of assisting 
in the assembly of active transcription factors; (III) the formation and transport of the 
activated transcription factors and (IV) the recognition in the nucleus of the specific DNA 
site. Each of the steps, involved in IFN-alp and IFN-y activated transcription will be 
discussed below. 
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1.1.3 lEN receptors 
All cellular responses to IFNs require the interaction 01 the ligand with a low number 
01 high·affinity, species specilic cell surlace receptors. Although it was originally thought 
that a single receptor existed lor all IFNs, it is now known that there are two types 01 
receptors, one which interacts with type I IFNs, and a second receptor that binds type II 
IFN (Pestka, 1986b; Pestka et aI., 1986c; Aguet et aI., 1988; Langer and Pestka, 1988; 
Uze et al., 1990; Uze, 1992). 
1.1.3a IFN·alO or type I IFN receptor 
The type I receptor permits the productive binding 01 IFN·p and the many related 
subtypes 01 IFN·a (Uze, 1992). IFN·alp subspecies differ considerably in their affinity lor 
the receptor, which correlates with the level and type 01 biological activity (Hu et aI., 
1990). 
The human receptor cDNA contains an open reading frame encoding a protein of 64 kDa 
(Uze et aI., 1990), the corresponding gene has been mapped to the long arm 01 human 
chromosome 21 (21q22.1; Langer et aI., 1990; Lutlalla et aI., 1990). Cross·linking 
studies, however, yielded apparent molecular weights (Mr) in the range 01 110·140 kDa 
lor the Hu IFN·alp receptor. This discrepancy may be due to the presence 01 glycosyl 
groups at any 01 the 15 different potential glycosylation sequences (Uze et aI., 1990). 
Complexes of higher Mr's have also been obse:rved, an indication that the receptor may 
interact with one or more other polypeptides. 
The extracellular region of the type I receptor contains the ligand binding domain 
and is composed of a duplicated region which suggests the existence of two functional 
ligand binding domains with varying affinity lor one or another homolog 01 type I IFN 
(Bazan, 1990a; Bazan, 1990b). Binding alone ligand to a particular domain may affect 
binding of another to the second domain. This mechanism may account for the multiplicity 
01 binding affinities and receptor occupancies lor IFN·a subtypes (Uze et aI., 1985; 
Mogensen et al., 1989). The intracellular domain is very short, but is probably involved in 
the signal transduction pathway, although no specilic lunctions have been assigned (lor 
example, it lacks a tyrosine kinase domain or multiple membrane spanning domain). 
Indirect evidence suggesting a multi-subunit receptor or species specific coupling system 
between the receptor and cellular machinery has been presented by several groups (Jung 
and Pestka, 1986; Uze et al., 1990). When overexpressed in mouse cells treated with Hu 
IFN·aB and .p, the human type I receptor conlers the antiviral phenotype. In addition it will 
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mediate MHC induction when transfected into mouse NIH3T3 cells. However, the product 
of this receptor alone is not sufficient to elicit a response to some other Hu IFN-a species 
in the transfected cells, suggesting the requirement for an accessory component(s) to 
reconstitute the response to all type IIFNs. Some of these factors may be species specific 
(Jung and Pestka, 1986; Uze, 1992). 
1.1.3b IFN-y or type II IFN receptor 
The native IFN-y receptor has been purified and characterized from several cell lines 
and human placenta (Rashidbaigi et aI., 1985; Aguet and Merlin, 1987; Calderon et aI., 
1988; Fountoulakis et aI., 1989; Stefan os et aI., 1989; Van Loon et aI., 1991). Like the 
IFN-alp receptor, the IFN-y receptor is a single chain glycoprotein. It has an apparent Mr 
of about 90 kDa (Rashidbaigi et aI., 1985; Aguet and Merlin, 1987; Calderon et al., 1988; 
Fountoulakis et aI., 1989; Stefan os et aI., 1989; Van Loon et aI., 1991). It has an 
extracellular, a transmembrane and an intracellular domain. The apparent Mr of the 
receptor from the different cell lines showed variations from 90 to 110 kDa, which could 
result from differences in glycosylation of the extracellular domain (deglycosylation 
resulted in a Mr of 70-75 kDa). Glycosylation is not essential for the interaction with the 
ligand (Fountoulakis et aI., 1989). 
The human IFN-y receptor cDNA (Aguet et aI., 1988) encodes a protein of 489 
amino acids, the gene has been mapped to human chromosome 6q (Rashidbaigi at aI., 
1986; Jung et aI., 1987). The complete extracellular domain of the mature human IFN-y 
receptor carrying the ligand binding site has been expressed in E. coli, insect and 
eukaryotic cells (Fountoulakis et al., 1990a; Fountoulakis et aI., 1991). The soluble IFN-y 
receptor expressed in E coli, binds IFN-y in its dimeric form (Fountoulakis et aI., 1990b). 
Comparison of the extracellular domain protein sequences for the type II and type I 
receptors suggests a similar ligand binding domain of approx. 210 residues (albeit repeated 
in the type I structure) with characteristic cysteine pairs at both amino- and carboxy~ 
termini (Bazan, 1990a). Two distinct regions of the intracellular domain play an important 
role in mediating the functional activity of the IFN-y receptor (Farrar et aI., 1991): a short 
membrane~proximal region of 48 amino acids, which contains a consensus motif found in 
the intracellular domains of a variety of rapidly internalized receptors, such as the 
transferrin receptor (Collawn et aI., 1990) and the mannose phosphate receptor (Canfield 
et al., 1991), and three carboxy-terminal amino acids (Tyr-Asp·His) IFarrar et aI., 1992). 
The intracellular region of IFN-y receptor, like the IFN-alp receptor, does not contain any 
obvious catalytic domains. 
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Human IFN·y receptors expressed in mouse cell lines with or without human chromosome 
21, were fully capable of binding, internalizing and directing the degradation of ligand. 
However, only the man/mouse somatic hybrids carrying human IFN·y receptor and human 
chromosome 21 were responsive to human IFN·y. To reconstitute functionallFN·y receptor 
the presence of a species·specific component(s) encoded by human chromosome 21, 
interacting with the extracellular domain of the IFN·y receptor, is required (Hemmi and 
Auget, 1991; Hibino et al" 1991; Kalina et al., 1991; Soh et al" 1993). 
Comparison of extracellular domains of different cytokine receptors supports the 
view that the receptors for growth factors, IFNs, and Iymphokines may exhibit a 
convergence of structure, that is not evident in the amino acid sequence (Bazan, 1990a; 
Bazan, 1990b). An analysis of the sequences, which may be predictive for the secondary 
structure, further supports the idea that the extracellular domains of the IFN receptors 
share a common three·dimensional architecture formed by amphipathic p strands typically 
found on globular proteins. Therefore, the multisubunit structure of several cytokine 
receptors might serve as a paradigm for the organization of the IFN receptors. The finding 
that the intracellular regions of IFN·alp receptor and IFN-y receptor do not possess any 
obvious catalytic domains, suggests that they interact with crucial signalling components, 
as has been demonstrated for other cytokine receptors. 
1.1.4 IFN-inducible genes 
As previously mentioned, the type I and type IIIFNs, through their interaction with 
their different receptors, induce the expression of partially overlapping sets of cellular 
genes. Some of these genes are induced in common by the type I and type I! IFNs, 
whereas others seem to be preferentially induced by one of the IFN types. The similarities 
and differences in the biological properties of the type I and type I! IFNs may be a 
reflection of partially overlapping and differential regulation of cellular genes by the two 
types of IFNs. 
A search for IFN-induced proteins responsible for mediating the antiviral and other 
effects of IFNs led to the identification of novel enzymes (e.g., two double stranded RNA-
activated enzymes: a protein kinase and a 2'-5'-0IigoA synthetase (2-5AS), eel! surface 
molecules (e.g" MHC class I and class II antigens, Fe receptors] and a number of new 
proteins (Sen and Lengyel, 1992). A direct role in the antiviral actions of IFN has been 
demonstrated for the Mx protein and the 2-5AS systems. It is, however, beyond the scope 
14 
of this thesis, to cover the aspects of the numerous properties of IFN-induced proteins. For 
a more detailed review concerning this topic see refs. Pestka et aI., 1987; De Maeyer and 
De Maeyer-Guignard, 1989; Sen and Lengyel, 1992. 
1.1.4a IFN-alP-stimulated genes 
A group of approx. 16 directly IFN-alp regulated genes (lFN-stimulated genes or 
ISGs) has been identified. The characterization of their transcriptional response to IFN-a 
by using in vitro nuclear transcription assays and in vivo promoter analyses has revealed 
distinctive features of ISG regulation (Friedman et al .. 1984; Larner et al .. 1984; Faltynek 
et al., 1985; Friedman and Stark, 1985; Larner et aI., 1986; Levy et al .. 1986; Williams, 
1991; Sen and Lengyel, 1992). ISG mRNAs are detected in cells within about one hour 
of treatment with type IIFN. In some cases, the mRNAs accumulate to a steady-state level 
which is maintained for many hours. In other ca1ses, the mRNAs are induced to a peak level 
which then declines, despite the continued presence of IFN (Friedman et al .. 1984; Larner 
et al .. 1984; Revel and Chebath, 1986; Sen and Lengyel, 1992). The induction of gene 
expression by IFNs is often of great magnitude, reaching high rates of transcription from 
nearly undetectable levels. Although the induction is primarily at the transcriptional level 
(Friedman et al .. 1984; Larner et al .. 1984), additional regulation at a post-transcriptional 
level has been proposed in certain cases (Friedman et aI., 1984). Induction of transcription 
will occur even in the absence of cellular protein synthesis. The transcriptional response 
of ISGs correlates with receptor occupancy (Hannigan and Williams, 19861. Analysis of 
a number of ISGs has allowed the identification of regulatory sequences that determine 
their inducibility by IFNs. This led to a refinement of the IFN-responsive regulatory 
sequence. A consensus sequence NAGTTTCNNTTTCITNN [where N is any nucleotide], 
designated as the interferon-stimulated response element (lSRE), has been determined. A 
list of genes containing the ISRE is presented in Table 1. The ISRE exists in ISGs in either 
orientation, sometimes in multiple copies, and (minor) variations from the consensus 
sequence have been found in individual ISRE sequences. Functional analysis of the ISG-
15K gene (Reich et aI., 1987; Reich and Darnell, 1989), and a variety of other inducible 
genes (Levy et aI., 1986; Israel et aI., 1986; Benech et al .. 1987; Sugita et aI., 1987; 
Wathelet et aI., 1987; Cohen et aI., 1988; Hug et al., 1987; Kessler et al .. 1988a; Levy 
et al .. 1988; Porter et al .. 1988; Rutherford et al .. 1988; Dale et al .. 1989a; Reid et al .. 
1989) has demonstrated that ISRE is necessary for IFN induction. It appears, therefore, 
that the IFN-alp-induced expression of cellular genes is mediated through a common 
response enhancer element, the ISRE. 
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TABLE 1 REPRESENT A TIVE ISRE SEQUENCES 
Gene Species ISRE Ref. 
ISO-15 human CAGTTTCGGTTTCCC Reich at a1. I 1987 
ISO-54 human 'TAGTTTCACTTTCCC Wathelet at a1., 
CAATTTCACTTTCTA 1987 
ISO-56 human TAGTTTCACTTTCCC Wathelet at al., 
CCCTTTCGGTTTCCC 1987 
6-16 human GAGTTTCATTTTCCC Porter at al. I 1988 
CAGTTTCATTTTCCC 
9-27 human AAGTTTCTATTTCCT Reid at al., 1989 
GBP human TACTTTCAGTTTCAT Lew at a1., 1991 
HLA class I human CAGTTTCTTTTCTCC Pellegrini and 
schindler, 1993 
2-SAS human TGGTTTC-GTTTCCT, Cohen at al., 1988 
IP-IO human AGGTTTCACTTTCCA' Ohmori at al. I 1993 
Factor B human CAGTTTCTGTTTCCT Wu at al., 1987 
MxA human AGGTTTC-GTTTCTG Chang et al., 1991 
GAGTTTC-ATTTCTT 
H-2K mouse CAGTTTCACTTCTGC Pellegrini and 
schindler, 1993 
H-20 mouse CAGTTTCACTTTTGC Pellegrini and 
schindler, 1993 
H-2L mouse CAGTTTCCCTTTCAG Pellegrini and 
Schindler, 1993 
202 mouse CAGTTTCTCATTTAC pellegrini and 
Schindler, 1993 
Mx mouse GAGTTTCGTTTCTGA Hug et al., 1988 
2-SAS mouse CAGTTTCCATTTCCC Cohen et al., 1988 
p2m mouse CAGTTTCATGTTCTT Pelligrini and 
Schindler, 1993 
Consensus NAGTTTCNNTTTCNN 
T 
1.1.4b Genes regulated by IFN-y 
There are also genes that are known to be activated immediately at the 
transcriptional level by IFN-y. In this respect. the study of the guanylate-binding protein 
(GBP) gene, which is inducible by both IFN-y and IFN-alp, has led to the identification of 
the IFN-y activation site or GAS, in addition to an ISRE (Decker et aI., 1989; lew et al .. 
1989; lew et aI., 1991). In Hela S3 cells, GBP mRNA accumulated in response to IFN-a 
or IFN-y. For boths IFNs, the induction was transcriptional and primarily direct. The kinetics 
of GBP mRNA accumulation in response to types I and IIIFN were markedly different, with 
IFN-y producing a slowly-developing and long-lasting transcriptional induction, whereas in 
IFN-a treated Hela cells the GBP gene was transcribed with an abrupt onset and a rapid 
decay. A GBP promoter-reporter construct, containing an ISRE sequence, could be 
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activated by IFN-y or IFN-a. Deletion of the ISRE core abolished the response to both IFNs, 
but interestingly, base substitutions, which crippled the ISRE homolog for response to IFN-
a failed to affect induction by IFN-y. However, a promoter-proximal element overlapping 
the ISRE and termed GAS (see Table 2) was absolutely required for IFN-y to utilize the GBP 
fragment as an inducible enhancer. 
TABLE 2 IFN-y-RESPONSIVE SEO!-,ENCES 
Gene Species GAS 
GBP human ATTACTCTAAA 
FeyRI human TTTCCCAGAAA 
ICSBP human TTTCTCGGAAA 
IFP-53 human ATTCTCAGAAA 
IRF-l human TTTCCCCGAAA 
IRF-l mouse TTTCCCCGAAA 
Ly6E mouse ATTCCTATAAA 
mig mouse CTTACTATAAA 
Conaenaus NTTCCCNTAAA 
ATT G 
Lew at al., 1991 
Pearse at al., 1991 
Pellegrini and 
schindler, 1993 
Strehlow et al., 
1993 
Pellegrini and 
schindler, 1993 
Pellegrini and 
schindler, 1993 
Khan et al., 1993 
Pellegrini and 
schindler, 1993 
Recently, it has become clear that primary activation of other genes by IFN-y operates 
through a similar GAS-like element (see Table 2 for a partial list; consensus, 
NTT(C/A)(CIT)(CIT)N(T/G)AAA). Characterization of the IFP 53 promoter (Strehlow et al" 
1993) led to the detection of an IFN-y response region containing a GAS but no ISRE, 
whilB a 9 nt core region in the 3' domain of the GRR (lFN-y response region) of the FcyRI 
gBne promoter also resemblBs the GAS (Pearse et aI., 1993). These results support the 
conclusion that the GAS site has a more general role in the induction of transcription by 
IFN-y, comparable to the ISRE ih ISG induction upon IFN-a treatment (see 1.1.4a). 
Evidence accumulates that IFN-alp and IFN-y induction of gene expression is not 
as straight forward as presented as above. As already mentioned there is considerable 
overlap bBtwBen IFN·alp and IFN·y re9ulated genes. This overlap cannot bB explaned by 
the presence of both an ISRE and a GAS, as found in the GBP gene. The study of the Ly-
6A1E gene (Khan et aI., 1993), which is transcriptionally induced in cells exposed to IFN-
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alp or IFN-y, indicates that immediate IFN transcriptional response through the GAS 
element cannot only be used in genes inducible by IFN-y, but also by genes induced by 
IFN-a. Alternatively, in some cases not the GAS element, but the ISRE sequence has 
shown to be involved in immediate IFN-y trans~riptional response. The ISRE present in the 
IP-10 promoter (Ohmori and Hamilton, 1993) for example, was able to confer IFN-y 
sensitivity upon a heterologous promoter. Analysis of promoter constructs containing 
native and mutated ISREs suggested that this motif (see Table 1) is essential for the 
response of the 9-27 gene to IFN-y as well as IFN-alp (Reid et aI., 1989)_ The human 6-16 
gene, which contains ISRE sequence elements (highly homologous to the 9-27 ISRE; see 
Table 1) in the upstream region (Porter et al" 1988; Reid et al" 1989). is induced 
selectively by IFN-a and not by IFN-y, but the ISRE sequence of the 6-16 gene can confer 
inducibility to a reporter gene by both types of IFN (Reid et al" 1989). It was surmised that 
the context of the ISRE may determine the specificity of the response. A further study of 
the 6-16 gene did not reveal the presence of any IFN-y-specific negative regulatory element 
(Reid at aI., 1989). So, in conclusion it seems possible that under certain conditions, the 
IFN-y pathway can end up in activation of an ISRE, and IFN-alp might also be able to 
activate a GAS element. 
Further complexity of the system is derived from the indirectly activated genes. An 
example of this group are the MHC class II genes (Kappes and Strominger, 1988). their 
induction by IFN-y requiring ongoing protein synthesis (Blanar et aI., 1988; Amaldi et al" 
1989). An ISRE sequence, present in the upstream regulatory region of the HLA-DRa gene 
(member of the MHC class II genes), does not appear to be important for this secondary 
response to IFN-y (Basta et aI., 1988). The upstream regulatory region of MHC class II 
genes contains other unique features, which include several highly conserved sequence 
motifs (W, X and Y box) (Benoist and Mathis, 1990) that are required for IFN-y inducibility. 
Homologs of W, X and Y box sequences are also found in the invariant chain gene and are 
required for their constitutive, as well as IFN-y inducible expression (Eades et al" 1990; 
Brown et al., 1991). 
1.1.5 IFN-regulated DNA-binding factors 
1.1.5a Factors regulated by IFN-a/O 
Using electrophoretic mobility shift assay (EMSA), several protein factors have been 
identified which recognize the ISRE: ISGF1, -2 (lRF1) and -3, ICSBP, IBP-1 and IRF2 (Table 
3). The question now is, do all of these factors have a role in IFN-regulated gene 
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expression, and if so, what is this role. Interferon response factors 1 and 2 URF-l and IRF-
2), IBPl and leSBP (Fujita et aI., 1988; Miyam~to et aI., 1988; Blanar et aI., 1989; Harada 
et al., 1989; Imam et al., 1990; Pine et aI., 1990) bind the central -11 bp core element 
of the ISRE which is shared with the IFN-P gene enhancer (Kessler et aI., 1988a). 
TABLE 3 
Namets) 
ISOF1 
IRF-1 
(ISGF2 ) 
IRF-2 
ICSBP 
IBP-1 
ISOF3 
ISRE-BINDING FACTORS 
Binding 
Specificity 
ISRE core 9 bp 
ISRE core 9 bp 
ISRE core 9 bp 
ISRE core 9 bp 
ISRE core 9 bp 
ISRE 
Protein 
Composition 
? 
37.3 kDa 
nuclear 
39.4 kDa 
nuclear 
48.2 kDa 
IRF-related 
59 kDa 
nuclear 
43.7, 84, 91 
and 113 kDa 
Potential 
Function 
suppressor 
of basal 
expression 
Activation 
of IFN-P 
gene 
Repression 
of activa-
ted IFN-P 
gene 
Repression 
of ISO 
transcrip-
tion 
IFN-y 
induced 
form of 
IRF-1 
Activation 
of ISG 
transcrip-
tion 
Levy et al., 
1988 
Miyamoto et 
al., 1988 
Pine et al., 
1990 
Harada et 
al., 1989 
Driggers et 
al., 1990 
Blanar et 
al., 1989 
Kessler et 
al., 1990 
However. the entire -15 bp ISRE sequence is required for transcriptional activity in 
response to IFN-alp (Kessler et aI., 1988a; Dale et aI., 1989a). In addition, these factors 
are induced in a protein-synthesis-dependent manner following exposure of cells to IFN-
alp, even though initial transcription of ISGs does not require new protein synthesis (Levy 
et aI., 1988; Miyamoto et al" 1988; Harada et aI., 1989; Driggers et aI., 1990; Imam et 
aI., 1990). Moreover, the timing of their induction is delayed, compared to the kinetics of 
transcription. These results suggest that, although these factors bind specifically to the 
ISRE, they are not involved in the (early) transcriptional activation of ISGs (see below). 
Interferon Stimulated Gene Factor 3 (lSGF3), a slowly migrating gel-shift complex, thusfar, 
is the only factor that fulfils the above criteria, therefore implicating it in transcriptional 
activation of ISGs (Levy et aI., 1989). 
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Characteristics and regulation of ISGF3 
The factor ISGF3 is induced very rapidly by IFN-alp without novel protein synthesis. 
The kinetics of appearance and decline of ISGF3 and its lack of dependence on protein 
synthesis correlate with the transcriptional activation and deactivation of IFN-alp-inducible 
genes (Levy et al .. 1988; Rutherford et aI., 1988; Dale et aI., 1989a; Levy et aI., 1989). 
The sequence requirements for ISGF3 binding at the ISRE correlate precisely with the 
requirements for transcriptional activation and its absence from IFN*a-resistant cell lines 
also correlates with ISG transcription (Kessler et al .. 1988a; Kessler et aI., 1988b; Levy 
et aI., 1988; Cohen et aI., 1989; Dale et al .. 1989a; Reich et aI., 1989). Furthermore, 
mutations in ISRE which affect the formation of the ISGF3 complex also affect its 
transcriptional response to IFN-a (Kessler et aI., 1988a). Finally, ISGF3 stimulates in vitro 
transcription from a template containing several copies of the ISRE sequence (Fu et aI., 
1990). Thus, ISGF3 apparently serves as a positive regulator in IFN-alp-mediated induction 
of cellular genes (Kessler et al .. 1988a; Kessler et al .. 1988b; Reich et al .. 1989; Levyet 
al .. 1989; Fu et al .. 1990). 
The activity of ISGF3 is apparently produced from pre-existing polypeptides (Levy 
et al .. 1989; Dale et aI., 1989b). ISGF3 could be induced in cytoplast preparations (free 
of nuclei) by trea.tment with IFN-a, but not in nucleoplast preparations (Dale et aI., 1989b). 
Moreover, it was observed that the level of active ISGF3 in cytoplasmic extracts of IFN-a 
treated cells could be increased by addition of extracts from untreated cells or, more 
dramatically, from cells treated with IFN-y (Levy et al .. 1989). These results have led to 
the conclusion that ISGF3 is formed from two components which have been designated 
ISGF3a and ISGF3y. 
The ISGF3y component is active and mostly cytoplasmic in untreated cells, but 
following IFN-a treatment it accumulates in the nucleus (Kessler et aI., 1990). Its induction 
by IFNy could contribute to the synergy between IFN-a and IFN-y (Levy et al .. 1990b)' 
ISGF3y was identified as a single polypeptide with an apparent Mr of 48 kDa, therefore 
als~ indicated as p48. It serves as the DNA recognition subunit and by itself already binds 
to the ISRE sequence with the same specificity as ISGF3, but with a much lower affinity 
(Kessler et aI., 1990). Recently, a eDNA encoding this protein has been isolated (Veals et 
ai., 1992). The deduced sequence of ISGF3y revealed at the amino terminus significant 
similarity to the three members of the interferon response factor (lRF) family of DNA-
binding proteins (lRF-lI1SGF2, IRF-2 and ICSBP; Veals et al .. 1992). Moreover, the 
conserved amino termini of these proteins are related to the DNA-binding domain of the 
c-myb-encoded oncoprotein (Howe et aI., 1990; Kanei-Ishii et aI., 1990; Gabrielsen et aI., 
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1991) (Figure 1). suggesting that they use a similar structural motif (a tryptophan-cluster 
helix-tum-helix) for DNA recognition (Veals et al" 1992). The carboxyl-terminal regions of 
these proteins diverge significantly. 
DNA Binding 
~============~c 600 
Transcr. 
Regulation 
Negative 
Regulation 
Figure 1. Schematic representation of the structural motifs in ISGF3y and IRF family members, and c-Myb 
{contaIning three Imperfect repeats, HI, R2 and R3, of tryptophan (WJ clusters]. 
ISGF3a appears to be composed of three cytoplasmic polypeptides. Activated 
ISGF3a has no detectable ISRE-binding activity, however, recently it has been suggested 
that in the active ISGF3 complex, one or more ISGF3a polypeptides may directly contact 
DNA (Veals et al" 1993). Complete purification of ISGF3a from IFN-treated Hela cell 
nuclear extracts resulted in the isolation of three proteins (p84, p91 and p113, 
respectively). Recently, cDNAs encoding these proteins have been cloned (Fu et al" 
1992a; Schindler et aI., 1992a). Sequence comparison shows thatthe p113 and p91/p84 
proteins have 42% sequence identity. Together, these proteins constitute a novel family 
of signalling proteins (Fu et aI., 1992a; Fu, 1992b). The p84 and p91 proteins are 
alternatively spliced products of one single gene. P91 contains at its carboxyl terminus 39 
additional amino acids to which specific antibodies have been targeted (Schindler at aI., 
1992a). 
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Figure 2. Schematic representation of structural motifs In pI 13 and p91/84. 
Th6 p113 and p91/p84 proteins contain several conserved structural motifs (Figure 2). 
such as a heptad leucine repeat. a helix·turn-helix; p113 has an acidic carboxy-terminal 
region (Fu et al" 1992a; Fu, 1992b). These motifs are commonly found in transcription 
factors (reviewed in Landschultz et aI., 1988; Ptashne, 1988; Lewin, 1990). Furthermore, 
it has been shown that p113 and p91/p84 contain well·conserved SH2 domains (Figure 
2) (Fu et al., 1992a; Fu, 1992b), which play important roles in facilitating protein'protein 
interactions among protein tyrosine kinase (PTK)-regulated proteins (reviewed in Koch at 
aI., 1991). SH3 domains (Mayer et aI., 1988; Stahl et aI., 1988), which have a possible 
role in protein traffic and subcellular localization (Koch et aI., 1991), have also been 
identified (Figure 2). In addition, conserved tyrosine residues were observed in p113 and 
p91/p84 (Figure 2) (Fu et aI., 1992a; Fu, 1992b). 
Activation of ISGF3 as a nuclear, DNA-binding protein is an early event in IFN-alp 
signalling, being detectable within 2 minutes following exposure of cells to IFN·a (Levy et 
aI., 1989). Some protein kinase inhibitors, such as staurosporine and genistein, can 
prevent both ISGF3 complex formation and ISG expression induced by IFN·a (Reich and 
Pfeffer, 1990; Fu, 1992b). indicating that activation of ISGF3 may involve protein 
phosphorylation. ISGF3a proteins, isolated by antHSGF3a protein antibodies from cells 
treated with IFN·Y plus IFN·a, are phosphorylated on tyrosine residues (Schindler et aI., 
1992b). In fact, a single tyrosine, Tyr 701. is phosphorylated in p91 (Shuai et aI., 1993a), 
and was shown to be important in ISGF3 activation. These events, which are likely to 
occur close to (or in association with) the cell membrane (David and Lamer, 1992; David 
at aI., 1993), trigger the association of these proteins in an immunoprecipitable complex 
with p48 (that is itself not phosphorylated in response to IFN·a), which translocates to the 
~ucleus (Schindler et aI., 1992b) and which has a 20 to 30·fold higher ISRE binding 
affinity than p48 itself (Levy et aI., 1989; Bandyopadhyay et aI., 1990; Kessler et aI., 
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1990). 
Immunoprecipitation experiments with p91-specific antibodies provided further 
insight into the nature of the ISGF3 complex. Only p113, and not p84, co-precipitated with 
p91, suggesting that two types of ISGF3 complexes could form (i.e. p113 + p91 + p48 or 
p113 + p84 + p48; Schindler et aI., 1992b). This finding was extended by the observation 
that overexpression of either p91 or p84 in a mutant line (U3), which is completely 
defective in the response to IFN-a (see also Table 4), restored ISGF3 binding activity and 
ISG induction by IFN'a (Pellegrini et aI., 1989; McKandry et aI., 1991; Muller et aI., 
1993a). 
IRF-1I1RF-2 
In studies of the transcriptional regulation of the human IFN-P gene, two interesting 
DNA· binding factors, IRF-1 (Miyamoto et al .. 1988) and IRF-2 (Harada et aI., 1989), were 
identified (see also Table 3). As mentioned earlier, the amino-terminal regions of these two 
factors, which confer DNA binding specificity, are structurally conserved (Figure 1) and 
related to the ISGF3y binding domain (Harada et aI., 1989; Veals et al .. 1992). 
Furthermore, both factors bind the same DNA sequence element, 
(G/A)(G/C)TTT(G/A)(G/C)TTT(T)G or IRF element, found not only within the promoters of 
IFN-as, IFN-P genes, but also in IFN·inducible genes (lSRE core) (Harada et al .. 1989; Naf 
et al .. 1991; Tanaka et aI., 1993). ISGF3 does not recognize the IRF element, indicating 
that for initial transcriptional activity in response to IFN·alp, a slightly longer sequence 
motif is required (Kessler at aI., 1988a; Dale at aI., 1989a). Overexpression experiments 
have shown that IRF-l functions as an activator on type IIFN genes and 18Gs, whereas 
IRF-2 represses the effect of IRF-1 (Fujita et al .. 1989a; Harada et aI., 1990). For example, 
evidence has been presented that IRF-1 appears to playa role in the induction of MHC 
class I and 2-5AS genes by binding to the ISRE (Harada et aI., 1990; Au et al .. 1992; Pine, 
1992; Reis et aI., 1992). In addition, IRF-1 overexpression in some cell lines leads to an 
antiviral state (Pine, 1992; Matsuyama et al .. 1993). On the other hand, kinetic studies 
for the IFN-inducible genes 2-5AS, PKR, 1-8, and H2-Kb, showed no significant difference 
between embryonic fibroblasts from IRF-1 deficient and wild-type mice (Matsuyama et aI., 
1993). So, conflicting data have been published and the physiological role of IRF-1 and 
IRF-2 in the regulation of 18Gs remains presently unclear. 
In a variety of cell types, both IRF-1 and IRF-2 mRNAs are constitutively expressed 
at low levels, however, IRF-2 dominates over IRF-1, binding at approximately 10-fold-
higher levels, as a result of its greater protein stability (Watanabe et aI., 1991). The IRF-1 
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gene is efficiently induced in response to virus and both types of IFN, resulting in an 
increase in IRF-1 activity relative to that of IRF-2 (Fujita et aI., 1989b; Harada et aI., 1989; 
Pine et aI., 1990; Watanabe et al" 1991). The IRF-1 gene is, however, also induced by 
other cytokines such as tumor necrosis factor a (TNFa), interleukin-1 (lL-1). IL-6, and 
leukemia inhibitory factor (LlF) (Fujita et al" 1989a; Abdollahi et aI., 1991; Watanabe et 
aI., 1991), implicating a role for IRF-1 and IRF-2 in determining the cellular response to 
these cytokines. Furthermore, IRF-binding sequences are seen within promoters of other 
cytokine and cytokine receptor genes (lL-4, IL-5, IL-7 receptor; Tanaka et al" 1993 and 
references therein), suggesting their involvement in a complex cytokine network. 
IRF-1 may play an inhibitory role in the regulation of cell growth (Yamada et aI., 
1990; Kirchhoff et al" 1992)_ln addition, it has been shown that IRF-1 and IRF-2 manifest 
antioncogenic and oncogenic properties, respectively, in NIH 3T3 cells (Harada et aI., 
1993). Hence, an imbalance in the IRF-11IRF-2 ratio may lead to the dysregulation of cell 
growth. which may be a critical step for oncogenesis. In this regard, it is of interest that 
the IRF-1 gene, which is mapped to human chromosome 5q31.1, is commonly absent in 
human leukemia and preleukemic myelodysplasia with deletion or translocations involving 
5q31.1 (Willman et al" 1993). 
1.1.5b Factors regulated by IFN-v 
An IFN-y-induced protein factor with affinity for GAS, in the promoter of the GBP 
gene was named y-IFN activation factor (GAF). GAF was induced in cytoplast preparations 
by IFN-y within 15 minutes, and the kinetics of its activation in cells correlated with the 
transcriptional activation of GBP (Decker et al., 1991). Thus, GAF may exist in a latent 
form in the cytoplasm and be rapidly activated following treatment with IFN-y. Upon 
activation GAF is translocated to the nucleus and binds GAS. The size of the protein that 
contacts DNA in the GAF-GAS complex was found to be about 90 kDa (Shuai et al" 1992; 
Igarishi et aI., 1993; Kahn et aI., 1993; Pearse et aI., 1993; Strehlow et al" 1993). a 
similar size as one of the ISGF3 proteins (p91) (Fu et aI., 1990; Fu et al" 1992a; Schindler 
at aI., 1992a; Schindler et al" 1992b). Experiments with specific antibodies directed 
against p91, subsequently showed that p91 participates in a GAF gel-shift complex, 
whereas p84 and p113 do not. It was suggested that p91 alone could be responsible for 
GAF activity (Shuai et aI., 1992). However, Igarashi et al. (1993) showed that the complex 
(FcRFy) binding to the FcyRI GAS-like region consisted of at least two protein components 
(p91 and an unknown 43 kDa protein). 
Staurosporine, an inhibitor of protein kinases that blocks the IFN-a-dependent 
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formation of ISGF3 (Reich et al., 1990) and the IFN·a·dependent phosphorylation of p91 
(Schindler et aI., 1992b), prevents also the appearance of the GAF DNA binding activity 
(Shuai et aI., 1992) and blocks the IFN-y-dependent transcription of the GBP gene in 
isolated nuclei (Shuai et aI., 1992). It turned out that GAF (p91) is converted to a form 
that binds DNA by IFN·y·induced phosphorylation on the same tyrosine (Tyr701) as in 
response to IFN-alp (Schindler et aI., 1992b; Shuai et aI., 1992). In contrast to p91. p84 
cannot activate GAS madiated transcription, although it was phosphorylated and 
translocated to the nucleus and bound DNA upon IFN-y treatment (Shuai et aI., 1993a). 
This observation was confirmed in experiments by Muller et al. (1993al, who showed that 
complementation of U3 mutants, (which lack p91/84) with cDNA constructs expressing 
p91 at levels comparable to those observed in induced Wild-type cells, completely restored 
the response to both IFN·a and IFN-y and the ability to form ISGF3 (Muller et aI., 1993a). 
Complementation with p84 similarly restored the ability to form ISGF3 and, albeit to a 
lower level, the IFN·a response of all genes tested. In contrast, it failed to restore the IFN-y 
response of any gene analysed. Thus, p91 mediates activation of transcription in response 
to IFN-y. 
The transcription factors involved in less well defined pathways (lFN-a via GAS; 
IFN-y via ISRE; indirect mechanisms) are less clear. In case of the Ly-BA/E gene, which 
uses a GAS element for mediating IFN-a and IFN-y induction, p91 appears to act in the 
signal transduction pathways of both types of IFN (Khan et aI., 1993). The ISGF3 complex 
is not activated by IFN-y (Levy et aI., 1990b). Therefore, IFN-y-induced transcription from 
ISRE-containing promoters is apparently mediated by a different factor(s). The IFN-y-
inducible IP-' 0 ISRE binding complex, of which the precise protein composition is unknown 
(Ohmori and Hamilton, 1993). could be detected as early as 30 min. after IFN-y treatment 
and was independent of protein synthesis. This indicates that induction of ISRE binding is 
c;t primary response to IFN-y and involves the activation of preexisting cellular factor(s). 
From the mutant cell line U2 (see also Table 4), which is unresponsive to IFN-alp, 
it has been suggested that ISGF3y (p48). may playa role in the activation of some but not 
all IFN·y·inducible genes. U2 cells express a truncated p48 protein, which is unable to 
interact with activated ISGF3a. While the IFN-y·induced activation of early genes is 
unaltered in U2, the activation of some genes is defective (John et aI., 1991; Pellegrini and 
Schindler, 1993). Interestingly, the antiviral response to IFN-y is strongly reduced in U2 
cells. 
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1.1.6 Tyrosine kinases involved In the IFN-a/O and IFN-v signalling pathways 
In the previous chapter it has been assigned that the specificity of the cytoplasmic 
response to IFN-a and IFN-y, at least partially, results from differential tyrosine 
phosphorylation of pl13, p91 and p84, which have also been termed signal transducers 
and activators of transcription, or STATs (Shuai et al" 1993a). 
The complementation of IFN-resistant mutant cell lines (Table 4) has provided direct 
evidence for the involvement of the JAK family of non-receptor protein tyrosine kinases 
(PTK) in the IFN response pathways. This family has so far three identified members, JAKl 
(Wilks, 1989; Wilks et al" 1991; Harpur et al" 1992; Howard et aI., 1992), JAK2 (Wilks, 
1989; Harpur et aI., 1992; Silvennoinen et al" 1993a) and Tyk2 (Firm bach-Kraft et al" 
1990). Each is about 130 kDa in mass and is characterized by the presence of a classical 
carboxy-terminal protein tyrosine kinase domain, an adjacent kinase or kinase-related 
domain and five further domains of substantial amino acid similarity extending towards the 
amino terminus (Harpur et al" 1992). 
Mutant cell line Ul (initially coded 11.1; Pellegrini et al" 1989), which contains 
functional pl13, p91/p84 and p48 genes, is impaired in its ability to bind IFN-as and 
activate ISGF3 (Pellegrini et aI., 1989). Genetic complementation of this mutant has shown 
that absence of Tyk2 is responsible for a defectious IFN-a signal transduction pathway 
(Velazquez et al., 1992). It is conceivable that Tyk2 represents the link between the IFN-
alp receptor and one or more of the ISGF3a proteins (Fu, 1992b). In principle, the SH2 
domains of these ISGF3 subunits could bind to phosphotyrosine in Tyk2 itself andlor to 
phosphotyrosine on one of the other subunits. Both kinase domains appear to be necessary 
for the biological activity of Tyk2 (Pellegrini and Schindler, 1993). Only a minor fraction 
of Tyk2 in the cell appears to be associated with the membrane, while a majority is 
cytosolic (Pellegrini and Schindler, 1993). Although the nature of the association of Tyk2 
with the cell membrane has not yet been defined, the lack of functionallFN-a binding sites 
in Tyk2-deficient cells suggests its interaction with receptor components. This is confirmed 
by David et al. (1993) who suggested that a membrane-associated tyrosine kinase was 
necessary for activation of ISGF3 by IFN-a. The normal response of Tyk2-deficient cells 
to IFN-y rules out the involvement of this PTK in the IFN-y pathway. 
Development of two other IFN-resistant eel/lines, provided direct evidence for the 
involvement of JAKl and JAK2 in the IFN response pathways. The U4A mutant celiline, 
which responds to neither IFN-a nor IFN-y, expresses a truncated form of JAKl mRNA and 
no JAK 1 protein, and can be complemented for both IFN-a and IFN-y responses by 
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TABLE 4 
Protein 
p48 
p84 
p91 
p113 
JARl 
JAK2 
TYK2 
COMPONENTS OF THE IFN-a/p AND IFN-y 
SIGNALLING PA THWA YS 
IFN-a IFN-v 
response response 
Required Not required 
Requiredl Not required 
phosphorylated 
Required! Requiredj 
phosphorylated phosphorylated 
(DNA-binding 
subunit) 
Required/ Not required 
phosphorylated 
Required! Required/ 
phosphorylated phosphorylated 
Not required Required/ 
phosphorylated 
Required/ Not required 
phosphorylated 
Mutant cell line 
U2 (IFN-a-, IFN-Y+ I 
p48-) 
U3 (IFN-a-, IFN-V, 
p84/p91-) 
U3 (IFN-a-, IFN-V, 
p84/p91-) 
No mutant known 
U4 (IFN-a-, IFN-Y I 
JAK1-) 
Y-l (IFN-a+ I IFN-Y, 
JAK2-) 
U1 (IFN-a:-, IFN-Y+ I 
TYK2-) 
overexpression of JAK1 (Muller et al" 1993b). The y1A mutant cell line is unable to 
respond to IFN-y (Watling et aI., 1993). However, y1A cells still respond to IFN-a, and 
have functional p113, p91/p84 and p48 genes. Overexpression of JAK2 in y1A cells 
restores IFN-y responsiveness (Watling et aI., 1993). 
In parental cells, IFN-y stimulates both JAK1 and JAK2 tyrosine phosphorylation. 
In y1A cells, which lack JAK2, JAK1 is not phosphorylated. Similarly, in U1 cells, which 
lack Tyk2, IFN-a fails to induce JAK1 phophorylation. In addition, IFN-a or IFN-y do not 
induce phosphorylation of either Tyk2 or JAK 1 in U4A cells (Muller et al., 1993b). This 
indicates that JAK PTKs cannot be placed in a linear order where one JAK PTK activates 
another, because if either JAK PTK in a pair is inactivated the other is not phosphorylated 
(Silvennoinen et aI., 1993b). 
27 
TYK2 ~I'-~I~ I ~'f, !J IF+~~ 'rtrP -+ c /' (~V - (;,)-{. / JAK1 ISRE r~J 
I JAK1 8 M IFNU 
--+ C 
JAK2 8-@-<O L GAS 
CYTOPLASM NUCLEUS 
Figure 3. Pathways of signal transduction and transcriptional activation In celts treated with IFN-a and IFN-y. 
Activation of JAK family PTKs by IFN-y and IFN-a is summarized in Figure 3 (see 
also Table 4), IFN-y elicits tyrosine phosphorylation of JAK1 and JAK2, which in turn 
phosphorylate p91. IFN-a induces phosphorylation of JAK1 and Tyk2, which in turn 
phosphorylate pl13 and p911p84. Both U1 and U4A cells fail to respond to IFN-a and lack 
functional Tyk2 and JAK1 respectively, which implies that both of these JAK PTKs are 
needed for the IFN-a response. Likewise, the failure of U4A and y1A cells to respond to 
IFN-y indicates that both JAK 1 and JAK2 are required for the IFN-y response. The presence 
of a common substrate, p91, and of a common PTK, JAKl, in the IFN-a and -y response 
pathways makes it tempting to speculate that JAK 1 might directly phosphorylate p91 
(Shuai et aI., 1993a; Shuai et al" 1993b) and that pl13, being unique to the IFN-a 
response, might be phosphorylated by Tyk2. The presumed substrate of JAK2 remains to 
be identified. 
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A possible clue to the activation mechanism comes from the demonstration that 
JAK2 directly associates with the erythropoietin receptor and growth hormone receptor 
and is activated upon ligand binding (Argetsinger et al" 1993; Witthuhn et al" 1993). If 
the two JAK PTKs required were to interact simultaneously with the cytoplasmic domain 
oj the relevant IFN receptor, this would facilitate mutual activation by transphosphorylation 
in a manner similar to that in which the two subunits of a ligand-bound receptor PTK dimer 
transactivate (Schlessinger and Ullrich, 1993). In response to ligand, these receptor PTKs 
dimerize and become auto phosphorylated on multiple tyrosine residues within their 
cytoplasmic extensions. These phosphotyrosine residues, in turn, allow the activated 
receptor to associate with other proteins (through SH2 domains) involved in signalling. 
JAK PTK activation might require the unusual protein kinase-like domain that lies 
to the amino-terminal side of the protein tyrosine kinase catalytic domain in these proteins 
(Wilks et aI., 1991). But the exact mechanism involved in JAK PTK activation may be more 
complex, because a protein-tyrosine phosphatase might also be involved (David et a!., 
1993; Igarishi et aI., 1993). 
1.1.7 Crosstalk between IFN and cytokine and growth factor signal transduction 
pathways 
Recently, it has become clear that tyrosine phosphorylation and activation of p91 
is not the preserve of the IFNs, and that many cytokines and growth factors, including 
epidermal growth factor (EGF), platelet derived growth factor (PDGF), colony-stimulating 
factor-l (CSF-1), and interleukin-l 0 (II-l 0), can induce tyrosine phosphorylation of p91 (on 
Tyr 701) or p91-related proteins and activate gene transcription through response elements 
related to GAS (Fu and Zhang, 1993; Larner et aI., 1993; Ruff-Jamison et al" 1993; 
Sadowski et al" 1993; Silvennoinen et aI., 1993c). For instance, it has been shown that 
the SIF (sis-inducible factor) response element in the c-fos gene, which has a core 
sequence related to the GAS element. binds tyrosine-phosphorylated p91 and that this 
activates transcription (Fu and Zhang, 1993; Sadowski et aI., 1993). Activation of p91 by 
'receptor PTKs shows some specificity because other cytokines, like IL-3, IL-5, and 
granulocyte-macrophage colony-stimulating factor (GM-CSF) can similarly activate 
complexes of DNA-binding proteins, but these complexes appear not to contain p91 
(Larner et al" 1993). 
29 
Binding of ligands, such as EGF or PDGF, to their receptors has already been proven 
to activate the Ras·pathway (Figure 4), including a series of protein kinases (mitogen-
activated protein kinase (MAPKI, MAP kinase kinase (MAPKK), and MAP kinase kinase 
kinase (MAPKKK)], and phosphorylation of the transcription factor AP-1 (Schlessinger et 
al., 1993). Phosphorylation of the latent cytoplasmic proteins p91 and SIF (possibly by one 
or more soluble tyrosine kinases associated through SH2 domains with the receptor) 
indicates a second, more direct pathway to the nucleus in these stimulated cells (Figure 
4). A JAK PTK may not be responsible for p91 phosphorylation in each of the cases. For 
-MAPKKK 
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MAPK I __ "_~ 
s- ~0-<. 
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Figure 4. Schematic representation of c-Ios promoter activation by EGFIPDGF via the HAS and the STAT 
pathways. 
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instance, some of the cytokines, such as EGF, directly activate receptor PTKs. Moreover, 
p91 binds to the activated EGF receptor, and both p91 binding and its ability to stimulate 
transcription depend on the integrity of its SH2 domain (Fu and Zhang, 1993), suggesting 
that the EGF receptor itself phosphorylates p91. However, because EGF induces specific 
phosphorylation of Tyr 701 (Shuai et al., 1993b), a JAK PTK may prove to be involved. 
So, what first appeared to be a membrane-to-nucleus transduction pathway unique 
to IFNs, became one that is almost universally activated by cytokines. The different 
cytokines that activate p91 do not all elicit identical cellular responses, so there must be 
as yet unidentified elements of specificity. This specificity may be determined by whether 
it is p91 or a p91-related protein that is activated, which in turn may depend on which 
'(JAK family) PTK is activated, and on the binding specificity of the p91 family member 
SH2 domain. There are three known PTKs of the JAK family, but there are likely to be 
more that may cooperate with JAK1, JAK2 or TYK2 to phosphorylate individual p91-
related proteins. Similarly, it is to be expected that the p113, p91/p84 (lSGF3-a) family 
is larger than the two members identified so far. 
In the case of IFN-alp and IFN-y, different sets of genes appear to be activated 
depending upon the subunit composition of the activated ISGF3 factor. Assembly of 
activated p91 and p113 into the ISGF3a component after IFN-a treatment allows 
association of this complex with ISGF3y (p48), that directs the complex to the ISRE unique 
to ISGs. In IFN-y treated cells, a p91 dimer binds to a distinct DNA element, GAS. Other 
cytokines induce GAS-binding activities with different mobilities (Fu and Zhang, 1993; 
Larner et ai., 1993; Ruff-Jamison et ai., 1993; Sadowski et ai., 1993; Silvennoinen etai., 
1993c), which suggest that there are additional subunits present in these complexes. 
Ancillary subunits could alter the DNA sequence preference of p91 family members, and 
it is becoming clear that there are several GAS-related sequences that have different 
affinities for p91 . So, a specificity-determining subunit may be involved in each signalling 
'pathway from a distinct receptor, combining with common p91 subunits and directing the 
complex to approptiate target genes. In this respect it is also possible that members of the 
ISGF3a family of proteins associate with various members of the IRF family of DNA-
binding proteins, including IRF-1, IRF-2, ICSBP, and c-Myb (Veals et al" 1992). 
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, .2.1 The ISG·54KIISG·56K gene family 
The human ISG·54K gene belongs to the first series of IFN-a regulated genes 
detected. Its mRNA synthesis is induced from undetectable levels to maximal rates of 
transcription within 30-60 min after the addition of IFN-alp to human fibroblast or to Hela 
cells (lamer et al .. 19841. After 6 hr of IFN treatment, the level of transcription declines 
and is undetectable after 24 hr. The accumulation of IFN-induced ISG-54K mRNA (2.8 kb 
in size) is detectable within 1 hr, lagging about 30 min behind the induction of 
transcription. The maximum concentration of cytoplasmic mRNA is observed after about 
6 hr of IFN treatment. After 24 hr the induced mRNA is present at < 1/1 Oth of its peak 
concentration, indicating that turnover reduces the mRNA concentration between 6 and 
24 hr. 
The ISG-54K gene is composed of two exons, interrupted by a 3.7 kb intron. Use 
of a putative poly(A) site in the 3' untranslated region and splicing of exons 1 and 2 would 
lead to production of a mRNA molecule of the observed 2.8 kb size. The open reading 
frame starts at the most 3'-end of the first axon, which is very short [(approx. 80 bp) and 
only provides the initiating methionine codon (ATG)). and encodes a protein of 472 amino 
acids with an approximately Mr of 54 kDa (levy et al .. 1986). The primary translation 
product would be very hydrophylic, rich in uncharged polar and charged amino acids 
residues, with the latter displaying a somewhat clustered distribution. 
The existence of an ISRE in the ISG-54K promoter (Table 1) and its specific DNA 
recognition requirements for ISGF3 and IRF1, have been established by extensive 
mutagenesis studies (levy et al .. 1986; Kessler et al .. 1988; levy et ai., 1988). 
The human genome contains at least one gene (lSG-56K), but most probably a 
small gene family, that is structurally related to ISG-54K (Wathelet et aI., 1986; Wathelet 
et aI., 1988a). The ISG-56K gene shows an organization identical to that of the ISG-54K 
gene: two exons, interrupted by an intron of unknown size, of which the first axon is very 
small (approx. 90 nt) and only provides the initiating methionine codon. Use of a putative 
poly(A) site in the 3' untranslated region and splicing of exons 1 and 2 would lead to 
production of a mRNA molecule of 1.9 kb. The open reading frame encodes a protein of 
478 amino acids with an approximately Mr of 56 kDa (Wathelet et al .. 1986; Wathelet et 
al .. 1988a). The primary translation product, like that of ISG-54K, would be very 
hydrophylic. 
In human fibroblast or in Hela cells the accumulation of IFN-alp (and not IFN-y) -
induced ISG-56K mRNA (1.9 kb in size) is detectable within 1 hr (lamer et al .. 1984). The 
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maximum concentration of mRNA is observed after about 6 hr of IFN treatment, while a 
clear decrease in induced mRNA is seen after 24 hr. Interestingly, in human amniotic cells, 
the ISG-56K messenger was not only inducible with IFN-a but also with IFN-y (Wathelet 
et al" 1986). 
So, the ISG-54K and ISG-56K genes are regulated in a coordinate manner by IFN-
alp and lin human fibroblasts or in Hela cells) their mRNAs have a half-live considerably 
less than 8-10 hr and perhaps as short as 2-4 hr (larner et aI., 1984). Moreover, both 
genes are strongly homologous in sequence at the promoter (especially the ISRE region; 
Table 1), mRNA (60%), and protein (42%) levels. This strongly suggests that the ISG-54K 
and ISG-56K genes arose through a duplication of an earlier gene and diverged thereafter 
(Wathelet et aI., 1988a). Several observations indicate that the ISG-54KIISG-56K gene 
family is not restricted to these two members. The excistance of two pseudogenes 
homologous to the ISG-56K gene has been described (Wathelet et aI., 1988a). Together, 
the ISG-54K and ISG-56K genes and pseudo genes are mapped to human chromosome 10 
(10q23-q24) (lafage et aI., 1992). 
The homology between the 54 kDa and 56 kDa putative polypeptides, the 
similarities in their hydrophobicity and charge profiles, together with the conservation of 
six cysteine residues. suggest that the two polypeptides may adopt a similar secondary 
and tertiary structure, and hence might have a common biological activity (Wathelet at a!. 
1988a). The structure of the most conserved regions does not provide information about 
. a possible function of the proteins encoded by the ISG-54K and ISG-56K genes. Indirect 
evidence, points to a role of the ISG-54K protein in the growth inhibitory pathway of IFNs 
(Van Heuvel et aI., 1988). It has also been suggested, however, that both proteins are 
involved in the antiviral effects of IFN (Wathelet et aI., 1988b). 
Interestingly, the coordenate regulation of the ISG-54K and ISG-56K genes is not 
restricted to IFN-alp, but also .direct induction by virus and polylll.poly(C), and other 
cytokines (like Il-1 or TNF) of both genes is seen (Wathelet et aI., 1987; Reich et aI., 
1988; Wathelet et al., 1988b). This could indicate a common mechanism, using 
overlapping DNA requirements, involved in regulation of these specific genes. Therefore, 
these genes may serve as a perfect system to study the mechanisms of signal transduction 
induced by IFNs and other cytokines. 
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1.2.2 Scope of the thesis 
IFNs mediate a wide variety of effects on target cells. Therefore they are an 
interesting system to study the mechanisms of action of cytokines. In addition, IFN-
regulated gene expression provides a particularly attractive system in which to examine 
how transcription in the cell nucleus is governed through occupation of a cell-surface 
receptor by its polypeptide ligand. As part of our ongoing work on IFN-regulated cell 
growth, this thesis describes the characterization of several hamster IFN-a subspecies and 
the characterization of IFN-induced transcriptional regulation of the ISG-54K/56K gene 
family. 
In Chapter 2 the structural analysis and chromosomal location of four closely linked 
hamster IFN-a genes (A 1-A4) are described. Specific antiviral activities of the A 1 and A3 
proteins, on hamster and on mouse cells, are presented. 
Chapter 3 describes the molecular cloning and characterization of the hamster ISG-
54K gene. Chapter 4 includes the molecular cloning, characterization and chromosomal 
localization of the mouse ISG-54K/56K gene family. Together, these two chapters identify 
the presence of an ISRE-doublet in the promoter of these genes, and its functionality upon 
IFN-a treatment. 
Chapter 5 describes the role of the ISRE sequences in the IFN-y regulation of the 
ISG-54K promoter. Evidence is presented for a role of the transcription factors 
p91 (lSGF3a) and p48(1SGF3y), but not p113(1SGF3a). in this process. 
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SUMMARY 
Three recombinant phages containing hamster Interferon-a genes (Ha IFN-a) were 
Isolated from a hamster genomic library. using a mouse interferon-a (Mu IFN-a) probe. The 
phage Inserts contained overlapping hamster genomic fragments, spanning a total length 
of approx. 30 kb. and four Ha IFN-a genes (Ha IFN-a A 1. -A2. -A3 and -A4). The IFN-a 
gene cluster could be assigned to hamster chromosome 2. The nucleotide sequences of 
the four IFN-a genes were determined. Two of the genes are functional (Ha IFN-a Aland-
A3) and two are pseudogenes (-A2 and ·A4). The Ha IFN-a Aland ·A3 genes were 
transiently expressed in COS cells and they gave rise to protein products with antiviral 
properties on hamster CHO cells. In addition, A 1 revealed high antiviral activity on mouse 
L929 cells. 
INTRODUCTION 
Interfer~ns (IFNs) are a family of proteins with various biological properties. IFNs 
are secreted by the producer cells in response to different inducers, and can induce a 
variety of responses in target cells. These include antiviral, cell growth inhibiting, and 
immunomodulatory activities (see for reviews Pestka et aI., 1987; De Maeyer and De 
Maeyer-Guignard. 1988; Sen and Lengyel. 1992). 
The IFNs have been classified into two types on the basis of their biological and 
physical properties. IFN·p and IFN-a are members of the Type I IFNs. In all mammalian 
species studied, the a IFNs are encoded by a family of intronless, closely related genes 
(Weissmann and Weber. 1986; De Maeyer and De Maeyer-Guignard. 1988; Sen and 
Lengyel. 1992). In the human genome at least 14 active IFN-a genes (lFNA) (Diaz et al.. 
1993) and 4 pseudogenes (lFNP) can be discriminated. In addition. the human genome 
contains a series of IFNA·related genes (lFN·W genes) (Capon et al .• 1985; Hauptmann et 
al.. 1985. Diaz et al .• 1993). In the mouse genome. twelve different complete IFN·alpha 
genes have been isolated and characterized. Eleven of these [al. a2. a4. a5. a6T. a6P. 
aA. a8. a9. al0(7) and all) encode biologically active proteins (Shaw et al.. 1983; 
Daugherty et al .• 1984; Zwarthoff et al.. 1985; Kelley and Pitha. 1985; Dian et al.. 1986; 
Kelley et al.. 1986; Seif and De Maeyer-Guignard. 1986; Trapman et al .• 1988; Navarro 
et al.. 1989; Coulombe I et al.. 19911. the other is a pseudo-gene (LeRoscouet et al.. 
1985). 
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Human IFN-P (or IFN-B) is encoded by a single copy gene, which is 50% 
homologous to the IFN-a genes, and which is physically closely linked to the IFN-a gene 
family. The mouse genomB, in common with human, possesses a single IFN~P gene, 
whereas cows, sheep, and pigs possess multiple IFN-P genes (Weissmann and Weber, 
1986; De Maeyer and De Maeyer-Guignard, 1988). 
In human, Type I IFN genes are located within the band p22 of the short arm of 
chromosome 9 (Diaz et aI., 1991; Olopade et aI., 1992), in mouse, Type 1 IFN genes are 
clustered on chromosome 4 (Van der Korput et aI., 1985). Each member of the Type IIFNs 
contains 1 65~ 170 amino acid residues and binds to the same IFN receptor on the cellular 
membrane (Pestka et aI., 1987; De Maeyer and De Maeyer-Guignard, 1988). It is assumed 
that the IFN·a gene family arose by repeated duplications of a common ancestral a gene. 
The IFN-a genes are relatively well conserved. Within a speCies, the homology between 
the proteins is 70% or more. Between human and Mu IFN-a proteins the homology is 50 
to 60%. Despite these structural similarities, IFNas are relatively species-specific: most 
human IFNs have only a low activity on mouse cells and vice versa (Week 8t aI., 1981). 
The structural basis for this species specificity is unclear. 
Previously, we reported that some Mu IFN-a species are active on hamster cells, 
whereas others are not (Van Heuvel et aI., 1986). To increase our knowledge on the 
relationship of rodent IFNs we initiated a study on Ha IFNs. Here, we report the molecular 
characterization of a cluster of four Ha IFN·a genes, and its chromosomal localization. In 
addition, the antiviral activity of the proteins encoded by Ha IFN·a Aland ·A3 on hamster 
CHO-12 and mouse L929 cells, is described. The Ha IFN-a genes will form a basis for 
further comparison of hamster and mouse lFN'a properties. 
RESULTS AND DISCUSSION 
(A) Organization of the hamster IFN-a gene family. 
To isolate IFN'a genes, a hamster genomic library in AEMBL3 was screened 
according to standard methods (Sambrook et al" 1989). As a probe, a mixture of a 600 
bp BamHl/EcoRI Mu IFN-a4 fragment and a 600 bp BamHl/EcoRI Mu IFN-a6 fragment, was 
used (Zwart hoff et al" 1985). On Southern transfers of genomic DNA from hamster CHO 
cells, the probe hybridized to eight different fragments (Figure 1 AI. indicating that the 
hamster genome harbours an IFN·a gene family containing 8 or more different members. 
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FIGURE I. Isolation and characterization of a genomic cluster of four hamster IFN-(J genes. fA} Southern blot 
analysis of the IFN-(J genes In genomic DNA derived from hamster CHO cells. The DNA was digested with 
EcoRi. For hybridization. a 600 bp BamHI/EcoRi fragment containing the Mu IFN·a6 gene was used. (B) Partial 
restriction map of the hamster genomic DNA clones 3AII, 2A1', and 4A 14, containing the IFN·(J genes A " 
A3,A2, andA4 (boxed regions). Arrows indicate the direction of transcription. Methods. Thehamstergenomlc 
library, In AEMBL3, was a kind gift from C. Troe/stra (Erasmus University Rotterdam, Dept. of Cell Biology and 
Genetics). The library was screened according to standard procedures (Sambrook et al., 1989). A mix of a 600 
bp Bam HI/ECO RI Mu IFN·a4 fragment and a 600 bp Bam HI/EcoRI Mu IFN-a6 fragment (Zwarthoff et al., 
1985) was used as a hybridization probe. After three rounds of plaque purification, DNA was Isolated and 
characterized by restriction mappIng and Southern hybridization. 
After three rounds of plaque purification, ten recombinant phages were isolated. 
Five out of these ten phages were randomly chosen and further analyzed. DNA was 
isolated and characterized by single, double and triple restriction digestion and Southern 
blotting, using the Mu IFN·a6 gene fragment as a probe. The analysis indicated that the 
restriction pattern of three phages was identical (phage 3B 11)' whereas that of the other 
two inserts was unique (2A 11 and 4A 14. respectively) (Figure 1 B). The 3 different 
phages, containing inserts of 16·18 kb, were found to contain overlapping hamster 
genomic DNA fragments, and four regions hybridizing with the Mu IFN·a6 probe. The total 
size of the overlapping genomic fragments isolated was approx. 30 kb. A physical map of 
'the contig is shown in Figure 1 B. The different hybridizing regions correspond to four IFN-a 
genes, named Ha IFN-a A 1, -A2, -A3, and -A4, respectively. The genes A3 and A 1 are 
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separated by 8.4 kb, the distance between genes A3 and A2 is 3.2 kb, that between A2 
and A4 is 1.6 kb. The orientation of the A4 gene (as indicated in Figure 1 B) is opposite to 
that of AI, A2 and A3. 
(B) Chromosomal localization of the hamster IFN·a gene cluster. 
To determine the chromosomal localization of the hamster IFN'a genes, 
fluorescent in situ hybridization (FISH) on metaphase chromosome spreads from three 
different hamster cell lines (A23, CHO-12 and DON) was performed (see Legends Figure 
2). The biotinylated genomic clones 3Bll and 4A 14 (see also Figure 1 B), were used as 
probes for Ha IFN-a A4, -A2, and -A3, and Ha IFN-a AI, respectively. Eight to 15 
metaphases were analyzed for the different probes. 
FIGURE 2. Chromosomal localization of the hamster IFN-a gene cluster by in situ hybridization. (A) Metaphase 
from hamster A23 eel/line hybridized with the IFN-a A4, -A2, -A3 genes (probe 3811 j, demonstrating signals 
on two normal chromosomes 2 (indicated by an arrow) and an additional, abnormal chromosome 2. (8) DAPI 
staIning of the same metaphase as (A). Methods, the probes were labeled by standard nick translation with 
biotin-16·dUTP (Boehringer ManheIm). 50-100 ng probe in hybridization mixture (50% formam/de, 10% 
dextransulphate in 2xSSCPJ with 5 PO sonicated salm sperm DNA and 5 PO yeast tRNA, was heat denatured 
and preanneafed with 10 pg hamster cot-I DNA (Gibco BRl, Gaithersberg USA) for 30-50 min. at 37°C. The 
target DNA was also heat denatured (70°C, 2 min.) followed by hybridization overnight at 37°C. After 
washing, hybridization sites were visualized by immuno fluorescence using Avidine D-Fitc (Vector, USA). A 
second round of amplification was usually required. The slides were counterstalned with propldium Iodide and 
4:s',diamino-2-phenyfindo/e (DAPI) In antifade medium (DABCO). 
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The results of representative experiments are shown in Figure 2. Metaphases from 
the A23 cell line (Figure 2), hybridized with probe 3811 (Figure 2) or probe 4A 14 (data not 
shown), clearly demonstrated signals on both chromosomes 2. In 11 out of 15 cells, one 
additional abnormal chromosome 2 hybridized, whereas in 4 out of 15 cells this was the 
case for two abnormal chromosomes 2. Metaphases from CHO-12 and DON cell lines 
hybridized with probe 3811 or 4A 14 (data not shown), showed in all cases signals on one 
normal and one'abnormal chromosome 2. In conclusion, consistent signals for both probes 
were obtained only with chromosome 2. 
(e) The nucleotide sequence of the Ha IFN-a genes. 
Appropriate restriction fragments, including the different genes, were subcloned 
and further characterized by restriction mapping and sequencing. The nucleotide sequences 
of the different genes are compared in Figure 3. The translation initiation codon (ATG) and 
presumed stop codons are underlined. In the IFN-a A 1 and -A3 genes proper open reading 
frames (ORF) were found encoding proteins of 190 and 189 amino acids, respectively. The 
IFN-a A2 and -A4 genes, on the contrary, both showed reading frames, interrupted by 
stop codons, which would result in the synthesis of truncated IFN proteins. 
Allignment of the sequences of Ha IFN-a A 1, and -A3 showed 91 % homology at 
the nucleotide level for the region beginning at the ATG start codon and ending at the 
termination codon TAA at position 669 (Figure 3). The homology between Ha IFN-a A 1 
and -A2 in this region is 85%. However, because of various insertions and deletions 
including an insertion of 16 bp, a TGA termination codon in A2 was found at position 200. 
The Ha IFN-a A4 gene contains a GTG at the position of the Aland A3 ATG first codon. 
This, and the further structure of the gene (the first termination codon is reached at 
position 165; see Figure 3) make it impossible that A4 encodes a functional IFN. The 
homolgy between the sequenced part of Ha IFN-a Aland -A4 genes, is only 66%. Starting 
from position 81 (codon 1 ATG/GTG) until position 487 the homology is still 86%. From 
. position 488 on, the sequence from A4 completely diverges from A 1. 
FIGURE 3. Homology between the nucleotide sequences of the hamster IFNa-Af, -A3, -A2, and -A4 genes. 
The transcript/on start site is indicated as + f. The initiatIon codon (ATG) and presumed stop codons (TGA, 
TAG, TAA) are underlined. The TGT codon, that marks the begInnIng of the mature protein, is overl/ned. Dots 
Indicate homology, horizontal bars indicate deletions. A variant TATA-box is indicated by TATA. Mothods. 
Nucleotide sequences were determIned by the dideoxy chain termination method (Sanger et al., 1977), using 
T7 polymerase (Pharmacia, Uppsala, Sweden). 
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At approximately 30 bp upstream from the presumed transcriptional start site 
(indicated as +1 in Figure 3; see also Shaw et ai, 19831. in A1 and A3 a variant TATA 
box (TATTTA) is found, which is a characteristic of IFN-a genes, In the small stretch of 
3' untranslated region, no polyadenylation signal could be detected, 
(0) Structure of the Ha IFN-a A 1 and ·A3 proteins, 
A comparison of the amino acid sequences of the Ha A 1 and A3 proteins as 
deduced from their nucleotide sequences is shown in Figure 4. By comparison with the 
sequence of selected Mu IFN-a proteins (Mu aI, a4 and a6; Zwart hoff et al" 19851. the 
first 23 amino acids presumably represent the signal peptide (Figure 4). This sequence is 
enriched in hydrophobic amino acid residues, Ha-A 1 and -A3 show a high homology (87%) 
in their signal peptide, between hamster and the three mouse species the homology is 
approx. 80%. The cysteine residue at 821, but not that at 85, is concerved in hamster and 
mouse sequences. 
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FIGURE 4. Comparison of the amIno acId sequence of Ha IFNa-A 1 and -A3 with that of the mouse IFN-a 1, -04, 
and -06. Conserved cysteines are indicated by arrow heads, Gaps (-J were introduced to maxImIze allignment. 
Dots Indicate homology and asterisks indicate deduced endpoints, Numbering starts from the mature protein, 
which Is preceeded by the signal peptide. 
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The mature proteins, encoded by A 1 and A3, are 167 and 166 amino acids in 
length, respectively, and show 85% homology. Between hamster and mouse subspecies 
this homology varies from 70% (A 1/04) to 80% (A31a6 and A3Ia1). The five cysteine 
residues present in all Mu IFN·a species at positions 1,29,86,99 and 139 are also found 
in Ha A 1 and Ha A3. Cys 1·cys99 and cys29·cys 139 can form disulfide bridges (Wetzel 
et aI., 1981). A1 and A3 do not contain the N·glycosylation site (Asn·Ala· Thr) at 79 to 81 
found in most mouse IFNs (Trapman et aI., 1988). 
From site·specific mutagenesis, hybrid scanning, competitions with specific 
anti peptide antibodies, and the crystal structure of Mu IFN·p, it is believed that three 
functionally important segments, defined by residues 29·35, 78·95, and 123·140, of the 
IFN-a molecule are required for receptor binding and activation of specific responses 
(Nisbet et aI., 1985; Eichmann et al., 1990; McMullen et aI., 1990; Fish et al., 1992; 
Senda et al., 1992; Waine et aI., 1992). Site· directed mutagenesis of the human IFNs·a 
has furthermore shown that Leu·30, Arg·33, Phe·36, and Tyr·123, all located in 
hydrophilic regions, are critical for antiviral activity. These residues are conserved in the 
Ha and Mu IFN-a sequences, as depicted in Figure 4. The overall comparison of segments 
29·35,78·95, and 123·140, between the different species showed no important sequence 
differences, indicating conservation of essential domains between IFNs from different 
species. 
(E) Expression and biological activity of the Ha IFN·A 1 and ·A3 proteins. 
The ORFs of Ha IFNa·A 1 and ·A3 were inserted into the polylinker of pSV328A, 
thus bringing the genes under the control of the simian virus 40 (SV40) early promoter 
(van Heuvel et aI., 1986). The resulting expression plasm ids, pSVA 1 and pSVA3, were 
transiently expressed in COS cells according to the calcium phosphate precipitation method 
(Chen et aI., 1987). IFN activity in the supernatant was subsequently assayed on hamster 
CHO and mouse L9 29 cells. Antiviral titers on CHO cells were related to the activity of Mu 
IFN·a6 (pSVa6) on CHO cells (Van Heuvel et aI., 1986). Mu IFN·a4 (pSVa4), which is only 
active on mouse L929 cells, was taken as a second control (Van Heuvel et al., 1986). 
Table 1 shows the values found in a representative experiment. It appeared that the Ha 
IFNa·A 1, and ·A3 genes coded for IFN subspecies with antiviral activity on hamster cells, 
as expected Mu IFN-a6 was also active on hamster cells and Mu IFN-a4 was not. The 
results obtained on mouse cells showed that Ha IFNa·A3 had almost no activity. 
Interestingly, the activity of Ha IFNa·A 1 on mouse cells was even higher than that of 06. 
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TABLE I. Antiviral activity produced by expression plasmids as measured on 
hamster (CHO-12) and mouse (L929) cells. 
CHO L929 
(U/m1) (IU/m1) 
pSVAl 6400 12S00 
pSVA3 12S00 16 
pSVa4 16 25600 
pSVa6 6400 3200 
IFN tltres on L929 were calculated relative to a NIH reference standard and are presented In IV/mI. TItles on 
CHO cells were compared to (hose on L929 cells and given In arbitrary Vlm/. 
Methods. All plasm/ds used for expression in COS cells were based on the expression plasmid pSV328A (Van 
Heuvel ef af .• 1986). For the construction of pSVA3, a Xholl-Msel (nt 50·765 in Figure 3) hamster IFN(J-A3 
fragment (the Msel site was blunt ended with Klenow DNA polymerase) was subcfoned Into pGEM7 (BamHI· 
Smal) (pGEMA3). The Insert was subsequently excised by EcoRI and Sacl digestion. and ligated Into the EcoRI 
and Sacl site of pSV328A. For the construction of pSVA 1 the pGEMA3 construct was used as a basis vector. 
By digest/ng pGEMA3 with Hincll and Asp718 (the Asp718 site was blunt ended), the complete mature protein 
coding region and a small part of the signal peptide coding region of A3 was excised. This vector was named 
pGEM-A3a. Because A 1 contains a conserved Hincll site at the exact same position as A3 (nt 132 in Figure 
3J, It was In principle possible to clone In a Hincll-EcoNI (nt 132-699) Ha IFNo-A 1 fragment (containing the 
, mature protein coding part of AI). FIrst, a Hlncll-EcoN! (nt 518-699J fragment /the EcoNI site was blunt ended) 
was cloned Into pGEMA3a. Secondly, the Hincll-Hlncll (nt 132-518) fragment of A 1 was ligated into this 
construct using the Hlncll site. The complete fragment was subsequently excised by EcoRl and Sacl and 
ligated Into the EcoRI and Sacl site of pSV328A. finally creating pSVA 1. In this way a complete Ha IFNa 
protein could be produced which conlained aA3-A 1 hybrid signal peptide and a mature A 1 protein coding part. 
COS cells were seeded at 5 x fer cells/6 em dish. The next day, cells were transfected with the appropriate 
IFN-a gene construct (5 Jig) according to the calcium phosphate precipitation method (Chen et al., 1987Ji 48 
hlater the medIum was collected. The amount of antiviral activity secreted during this period was assayed 
on hamster CHO 12 and mouse L929 cells In a cylophatic effect reduction assay, using vesIcular stomatltus 
virus (VSVJ as a challenge (Van Heuvel et al., 1986J. All experiments were carried out at least four times In 
duplicate with two separate plasmid isolatioflS. 
(F) Comparison of Ha and Mu IFN-a subspecies. 
The Mu IFN-al, ·a2, -a4 and ·a6 (see also Table 1) differ in their antiviral activity 
on hamster CHO cells and mouse L929 cells (Van Heuvel et al .. 1986). Structure-function 
analysis of several natural and hybrid Mu IFN-a species implicated the amino-terminal 
fragment ranging from amino acids 1 ° to 58 important for the activity on hamster cells 
(Van Heuvel et aI., 1988). A comparison of Ha AI, -A3, a6 and al (all active on hamster) 
with a4 (not active on hamster) (Figure 4), indicates 5 amino acids in this area (positions 
10, 19, 20, 45 and 55) in which a4 clearly differs from the other species (also as 
compared to Mu IFN-a2). This could indicate that amino acid residues at thsse positions 
are responsible for the difference in activity on hamster cells. 
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The carboxy-terminal portion of a4 (from amino acids 130 to 1 67) was found to 
be important for its high antiviral activity on mouse L cells (Van Heuvel et aI., 1988). 
Comparison of the carboxy-terminal 1130-end) portion of Ha·A 1, a4, a6 and al (all active 
on mouse) with Ha-A3 (not active on mouse) (Figure 4) shows no clear signs that could 
account for the difference in activity. This could indicate that not single amino acid 
differences, but more subtle differences in amino acids composition between A 1 and A3 
together, determine the difference in activity on mouse cells. 
tG) Comparison of promoter sequences. 
The region directly upstream from the TAT A box is known to be involved in the 
virus inducible expression of the IFN-a genes. Studies using deletion mutants have defined 
a region of the human IFN-a1 gene promoter, known as the virus responsive element (VRE; 
46 bp fragment extending from -109 to -64 relative to the cap site), which constitutes the 
minimum sequence necessary to confer full virus inducibility upon a minimal promoter 
(Ragg et aI., 1983; Weidle et al., 1983; Ryals et aI., 1985). Similarly, it was reported that 
the Inducible Element (IE; 35 bp fragment located between -109 and -75), which overlaps 
with the VRE, was able to confer inducibility to the Mu IFN-a4 gene (Raj et al., 1989). 
These elements contain repeats of the AGTGAA motif. or the variants of its permutated 
form GAAANN, which when multimerized (thereby resembling an IRF-l binding site) 
mediate virus inducibility upon a heterologous promoter (Naf et aI., 1991). The IE motif 
contains an almost symmetric sequence GTAAAGAAAGT (aFl, -103 to -94), which 
partially overlaps with a putative IRF-l binding site (Au et aI., 1993). It has been 
suggested that the integrity of both of these sites is essential for virus-mediated induction 
(Raj et aI., 1991; Au et al., 1993)' and that this requires cooperation between the aFl 
binding proteins and IRF-l or an other protein(s) binding to the IRF-l site (Au et aI., 1993). 
Differences in the VRE sequences of individuallFN-a genes in both mice and men, 
have been suggested to account for differences in the activity of their respective 
promoters (Bisat et aI., 1988; Civas et aI., 1991; Raj et al., 1991; Au et al., 1993). In 
Figure 5 the sequences of the VRE-corresponding region, containing aFl and the IRF-l 
binding site, of the Ha IFN-aA 1 and -A3 genes are shown together with the corresponding 
region of the Mu IFN-a4, -a6 and -all genes (Zwarthoff et aI., 1985; Raj et aI., 1991; 
Civas et ai, 1991) and the Hu IFN-al gene (Nagata et aI., 1980). Ha IFNa-A 1, like Mu IFN-
a6, contains a 4 bp deletion in aFl. The finding that a6 is transcriptionally active in mouse 
L cells (Zwarthoff et aI., 1985), indicates that this deletion is not distructive for activity 
of the Ha A 1 promoter. 
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Hu VRE ql 
Mu VRE q4 
a6 
all 
Ha VRE Al 
A3 
-109 VIRUS RESPONSIVE ELEMENT -64 
TAAAGAGTGCATGAAGGAAAGCAAAAACAGAAATGGAAAGTGGCCCAGAAGCATTAA 
IRF-l site 
-109 aFl -64 
CAGAGAGTGAAGTAAAGAAAGTGAAAAGAGAATTGGAAAGCAAGGGGAGGGTATTCC 
T .•... A.A.GT. ---- ....•...• G .. C.G •..•..•. TT .. A ..••.• C .••. A 
••.•..••..••....•...•••...•.....•... G ....•.....••.••..• TA 
.T .• A.A ... CTA---- ••... A •...• TAC .. G ..••.• T .. T .•..•.. C ... TA 
• T .. A.A .•• CTA •....••.. A ••..• T. T. -A •. G ... TC. T ....... C •.. CA 
FIGURE 5. Comparison of the Virus Responsive Element of IFN·<J genes [Ha IFN-o A 1 and ·A3, Mu IFN-a4. -06 
(Zwarthof{ et al .• 1985) and -all (elvas et al., 1991). and Hu IFN-al (Nagata et al .• 1980), respectively}. 
Gaps f.J were introduced to maximize allignment. Dots Indicate homology. The oFf and IRF-blndlng sile (Au 
et al., 1993) are indicated. 
Although Ha A1 has an IRF-Hike binding site, variation is seen at positions -98, -92 and-
86 as compared to 04. The Ha IFNo-A3 promoter seems to have an intact aF1 together 
with an IRF-1-like binding site, however, some variations in both elements are seen as 
compared to Mu IFN-a4. Especially, the T at position -103, instead of a G, in the aF1 
element seems an important difference being responsible for a lower activity (Raj et ai., 
1991). The IRF-1 site differs at position -92 and -86 as compared to a4. Mutation analysis 
from the Mu IFN-a11 gene, furthermore, suggested that the -78 A/G substitution (as 
compared to a4) affects the inducibility by decreasing the affinity of VRE-binding factors 
(Civas et aI., 1991). Interestingly, Ha A3 contains a G at -78, whereas in the other 
promoters a T residue is conserved at this position. Together, the structural data 
conoerning the Ha A 1 and A3 VRE region suggest that both genes can be expressed, 
although at a low level. 
(H) Conclusions 
(1) The organization of Ha IFN-a genes as determined here contributes to the 
. establishment of the IFN physical map from different species. The presence of more than 
one gene within a small piece of hamster DNA shows that the Ha IFNa genes are tightly 
linked in the genome, as was found to be the case for the human (Diaz et aI., 1991; 
Olopade et al .. 1992) and the Mu IFN-a gene family (Kelley et aI., 1983; Lovett et al .. 
1984; Van der Korput et al .. 1984). In the human genome, the Type IIFN genes have been 
assigned to chromosome 9 band p22 (Diaz et aI., 1993). in mouse to chromosome 4 (Van 
der Korput et aI., 1985). Our assignment of the hamster IFN-a genes to chromosome 2q 
is in good agreement with the human-mouse-hamster comparitive gene map (O'Brein and 
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Greaves, 1991). 
(2) Evidence that Ha IFNa-A2 and -A4 are pseudogenes is provided by the finding 
that although their nucleotide sequence is related to that of Ha IFNa-A 1 and -A3, they 
show many termination codons in the reading frame. The A2 and A4 genes both contain 
IfNa-like promoter sequences, indicating that a duplication from a functional IfNa gene is 
the most likely event for the origion of A2 and A4. The nucleotide sequence of A4 
diverged completely from A 1 at the 3'-terminus, which could mean that only a partial 
duplication or a DNA integration has taken place. 
(3) Ha IfN-as lack the N-glycosylation site present in most Mu IfN-as. A similar 
glycosylation site is found in the Hu and Mu IfN-P proteins, but not in Hu IfN-as (Higashi 
et aI., 1983; Pestka, 1983). The function of this glycosylation is not understood, but it is 
not necessary for the biological activity of Mu IFN-as as demonstrated by the antiviral 
properties of the Mu IfN-a6 protein. 
(4) Presently, we arB in the process of constructing mutants, with the objective 
of making the Mu IfN-a4 protein active on hamster cells. In this way we hope to find out 
more about the structural requirements of the Ha and Mu IFNa subspecies, important in 
activity on hamster cells. Similarly, A l-A3 hybrid constructs and A3-MulfNas can be 
prepared for the analysis of the important region for activity on mouse cells. 
(5) CHD cells are an excellent system to study the regulation of expression of IfN 
induced genes (Bluyssen et aI., 1994). The availability of Aland A3 IFN make it possible 
to investigate IFN-regulated promoters in a homologous system. 
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CHAPTER 3 
THE INTERFERON STIMULATED GENE 54K PROMOTER 
CONTAINS TWO ADJACENT, FUNCTIONAL INTERFERON 
STIMULATED RESPONSE ELEMENTS OF DIFFERENT STRENGTH, 
WHICH ACT SYNERGISTICALLY FOR MAXIMAL IFN-a 
INDUCIBILITY 
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SUMMARY 
The Interleron-a IIFN-al regulated hamster ISG-54K gene. which is activated In 
hamster CHO-12 cells at least 40-fold. was isolated and the promoter region was 
characterized in detail. Sequence analysis revealed the presence of two elements, closely 
related to the Interferon Stimulated Response Element (lSRE) consensus sequence 
[AGTTTCNNTTTCICITIl_ The putative ISRE-I sequence [GGTTTCAATTTCT) Is located at 
position -97 to -85; ISRE-IiIAGTTTTACTTTCTI. which differs at three positions from ISRE-
I. Is found directly upstream of ISRE-I at position -110 to -98_ In a transient transfection 
assay In CHO-12 cells the wlldtype hamster ISG-54K-promoter-CAT reporter construct 
showed a 40- to 80-fold Induction. offering an excellent model to study the functional 
properties of the two ISREs_ To find out whether both elements were functional in IFN 
regulation of the promoter, selected point mutations were introduced in the -110/-85 
region and in flanking sequences_ The Imutated) ISG-54K promoter was linked to the CAT 
reporter gene and transiently expressed in CHO cells In the absence and presence of 
MuIFN-a6_ Transfectlons showed that both the -97/-85 IISRE-I) and the -110/-98 IISRE-II) 
segment were needed for optimallFN induction of the ISG-54K promoter_ However. ISRE-I 
has an approx. seven-fold stronger activity as compared to (SRE-II. Sequential substitution 
of the three ISRE-I bases. which differ in ISRE-II showed that the T at position -105 causes 
the lower activity 01 ISRE-II_ Transfection of ISG-54K promoter constructs. in which ISRE-I 
was replaced by ISRE-II. which generates a promoter with two ISRE-II segments. and vice 
versa (two ISRE-Is), provided further evjd~nce for a role of both elements in IFN-a 
induction. Importantly, all data obtained in transfection studies show that the two ISREs 
cooperate synergistically. The mechanism of synergism Is most probably an indirect 
interaction between transcription factors binding to the ISREs. because an increase in the 
spacial arrangement of the two ISREs with a complete helical turn or half a turn did not 
result in a substantial decrease of promoter activity. 
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INTRODUCTION 
Type 1 interferons (lFN-alp) are a family of cytokines, which induce multiple 
cellular changes. The major biological responses of cells treated with IFNs are the inhibition 
of viral replication in these cells and a decrease in cell growth rate. During the last few 
years several steps of the molecular mechanism of the IFN induced signaling pathway have 
been elucidated, but many aspects remain unclear [s8e for recent reviews refs. 1,2]. 
IFNs interact with cells through specific cell surface receptors. The interaction of 
IFN·alp with its proper receptor ultimately results in the induction of the expression of a 
group of IFN·alp stimulated genes. IFN·alp induced gene expression is directly regulated 
on the level of transcription [3,4). Transcriptional stimulation in response to IFN treatment 
is at least partially mediated by preexisting cellular proteins, which become activated in 
response to the signaling pathway. Recently, it has been shown that a cytoplasmic protein 
tyrosine kinase (tyk2) is involved in the latter process (5). 
In general, directly IFN-alp stimulated genes isolated thusfar are characterized by 
the presence of a cis-acting DNA sequence IIFN-stimulated response element (lSRE)) in the 
promoter region. An ISRE consensus sequence AGTTTCNNTTTC(CIT) has been deduced 
from elements present in the different IFN-alp regulated promoters (see ref. 6 for 
examples). The ISRE specifically binds at least two trans-acting nuclear factors (or 
transcription tactorcomplexes) in a manner which correlates with transcriptional activation 
of the target genes [7,8). However, the involvement of other factors both in upregulation 
and downregulation of expression, cannot be excluded (7-13). One of the best 
characterized positive factors (lSGF2 or IRF-1(91. M(14), or C1-C2 (15)) is induced. upon 
IFN-a/p treatment, but induction requires protein synthesis [7,16). In cotransfection 
experiments, ISGF2(1RF-1) can bind to an ISRE and induce transcription from a target 
promoter [16-18). A second transcription factor, ISGF3 (E (14) or C3 (15)) is rapidly 
induced upon treatment of cells with IFN-alp, even without protein synthesis (7). 
Therefore, ISGF3 probably is the major transcription factor involved in the IFN-alp signal 
transduction pathway. In the absence of IFN·alp, ISGF3 is present in an inactive form in 
the cytoplasm. ISGF3 is composed of two protein components (ISGF3y and ISGF3a) 
(19,20). ISGF3y binds to the ISRE; the ISGF3a component (which is composed of three 
related proteins) seems to be activated by phosphorylation. In this way it directs ISGF3y 
to the nucleus, resulting in the formation of a more stable DNA-protein complex at the 
ISRE (20,21). 
Surprisingly little information is available about functional (mutational) analyses 
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of IFN-induced promoters. This seems to be due to absence of reliable transient 
transfection systems, which provide a high IFN-induction of the promoter. As presented 
in this study, we found hamster CHO-12 cells to be perfectly suited for these types of 
experiments. 
Expression of the human ISG-54K gene is known to be stimulated by IFN-alp 
, [22,23). To investigate the molecular basis of regulation of ISG-54K expression in a 
homologous system, the hamster ISG-54K gene was isolated and characterized. 
Subsequently, we explored a detailed functional characterization of the hamster ISG-54K 
promoter. Our data show that the ISG-54K promoter contains two functional ISREs of 
different strength, which act synergistically for maximal IFN-inducibility. 
MATERIALS AND METHODS 
Growth of cells and IFN treatment. Cells were maintained in Dulbecco's modified 
Eagle's medium supplemented with 5% fetal calf serum and antibiotics and subcultered 
by trypsinization. The supernatant of constitutively MuIFN-a6 producing CHO-12 cells 
(CHO-12 clone 28, which produces MuIFN-a6, a mouse IFN-a species which is active on 
both mouse and hamster cells, see refs. (24,25)) was used as the IFN source. MuIFN-a6 
was purified by affinity chromatography over an anti-MuIFN-a antibody column. Fo~ RNA 
isolation, CHO-12 cells were grown to 50% confluency and for a further 2, 4, 8, 24 or 48 
h in the presence (or continued absence) of MuIFN-a6 (50 IU/ml). CHO-12 cells to be used 
for transfection experiments were seeded at 5 x 105 cells per 6 em dish. After overnight 
transfection, cells were incubated for 24 h in the presence of MuIFN-a6 (50 IU/ml) or in 
the absence of IFN. 
Isolation of genomic clones from a hamster genomic DNA library. The hamster 
genomic library, in AEMBL3, was a kind gift from C. Troelstra (Erasmus University 
Rotterdam, Dept. of Cell Biology and Genetics). The library was screened according to 
standard procedures [26). A 561 bp EcoRI-EcoRI fragment, derived from exon 2 of the 
human ISG-54K gene [221, was used as a hybridization probe. After three rounds of plaque 
purification, DNA was isolated and characterized by restriction mapping and Southern 
hybridization. 
RNA analyses. Total cellular RNA was isolated by the guanidinium thiocyanate 
method [271. 20 Ji9 RNA was denatured by glyoxal treatment, separated by electrop-
horesis on a 1 ~o agarose gel and transferred to a nylon membrane (Gene Screen, New 
64 
England Nuclear (NEN), 80ston, MaJ, using the method described by the manufacturer. 
Filters were hybridized with DNA probes labelled as described [28J. Overnight hybridization 
at 42' C in 50% formamide and washing of the filters were as described by NEN and 
Sambrook et al. [26]. Filters were exposed to Kodak X-Omat AR film at -70' C using 
intensifying screens. 
Sequence analysis of the hamster ISG-54K gene. Nucleotide sequences were 
determined by the dideoxy chain termination method [29]. using T7 polymerase 
(Pharmacia, Uppsala, Sweden). 
Construction of plasmids. All plasmid constructs were prepared according to 
standard methods [26]. The promoterless plasmid pCAT·8asic (Promega, Madison, WI) 
was used as a basis vector to link the ISG-54K promoter fragment to the CAT reporter 
gene. For pHISG54-1-CAT, a 8amHI-Pstl (-4291+ 31) hamster ISG-54K promoter fragment 
was subcloned into pTZ19 (8amHI/Pstl). The insert was subsequently excised by Hindlll 
digestion, blunt ended with Klenow DNA polymerase, followed by Sacl digestion. The 
fragment was then ligated into pCAT-8asic (Sael, Xbal blunt ended I. 
In vitro mutagenesis by recombinant PCR. Mutations in the ISRE region (-110/-85) 
in the ISG·54K promoter were introduced according to the method of Higuchi et al. [30J. 
Standard amplification conditions were: 30 cycles of denaturation for 1 min at 95°C, 
annealing for 2 min at 55 °C, and extension for 2 min at 72 QC. Two outer primers were 
used (indicated below by 'of' and 'or', respectively: f = forward, r = reverse) and two, 
overlapping. inner primers (denoted by the name of the corresponding mutant: f = forward 
and r=reverse), which contained the mutation. The oligonucleotides which were used for 
generation of the different mutants are listed below. Residues in lowercase indicate 
differences from the wildtype sequence. 
or (+42 to +21) 5' TCAGTGCAGGCTGCAGCTCGCT 
of (-432 to -408) 5 ' GCGGATCCCTGCCACGCTATGGAGT 
pHISG54-2f 5 ' ATAAAAAGTGAtcaCAGTTTTACTTT 
pHISG54-2r 5' AAAGTAAAACTGtgaTcAcTTTTTAT 
pHISG54-3f 5' AGTGACATCAGgccTACTTTCTGGT 
pHISG54-3r 5' ACCAGAAAGTAggcCTGATGTCACT 
pHISG54-4f 5' GACATCAGTTTTACcagCTGGTTTCAATTTC 
pHISG54-4r 5' GAAATTGAAACCAGctgGTAAAACTGATGTC 
pHISG54-5f 5' TTACTTTCTGGccaCAATTTCTCTT 
pHISG54-5r 5' AAGAGAAATTGtggCCAGAAAGTAA 
pHISG54-6f 5' CTTTCTGGTTTcAAgagcTcTTCTGTGGGGT 
pHISG54-6r 5 ' ACCCCACAGAAGAGctcTTGAAACCAGAAAG 
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pHISG54-7f 5 ' GACATCAGTTTTACCAGCTGGTTTCAAGAGC 
pHISG54-7r 5 ' GCTCTTGAAACCAGCTGGTAAAACTGATGTC 
pHISG54-8f 5' TTCAATTTcTcgagTGTGGGGTCAG 
pHISG54-8r 5 ' CTGACCCCACActcGAGAAATTGAA 
pHISG54-9f 5' TTACTTTCTaGTTTtAcTTTCTCTTC 
pHISG54-9r 5' GAAGAGAAAgTaAAACtAGAAAGTAA 
pHISG54-I-If 5' AGTGACATCgGTTTcAaTTTCTGGTT 
pHISG54-I-Ir 5' AACCAGAAAtTgAAACgGATGTCACT 
pHISG54-9bf 5' TCTcgagtctagtAGTTTTACTTTCTCTTC 
pHISG54-9br 5' ACTagtagactcgAGAAAGTAAAACTGATG 
pHISG54-10f 5' TCTaGTTTCAATTTCTCTTCT 
pHISG54-10r 5' AGAAGAGAAATTGAAACtAGA 
pHISG54-11f 5' TCTGGTTTtAATTTCTCTTCT 
pHISGS4-11r 5' AGAAGAGAAATTaAAACCAGA 
pHISG54-12f 5' TCTGGTTTC~CTTTCTCTTCT 
pHISG54-12r 5' AGAAGAGAAAgTGAAACCAGA 
The PCR products were digested with BamHl/Psti, followed by insertio~ into 
peAT -Basic according to the procedure which was described for the construction of 
pHISG54-1-CAT, Construct pHISG54-9a-CATwasmade from pHISG54-9b-CAT. Digestion 
of pHISG54-1-CAT with Xhol and Spel, followed by self ligation, removes 5 bp. The 
structure of each mutant was confirmed by DNA sequence analysis. 
Transfection procedure and CAT assay. CHD-12 cells were seeded at 5 x 10' 
cells/6 cm dish. The next day, cells were transfected with the appropriate pHISG54-CAT 
reporter gene construct (2.5 /1g pHISG54-CATI according to the calcium phosphate 
precipitation method [31). After overnight incubation with the precipitate, incubation was 
continued in the absence or the presence of MuIFN-a6 (50 IU/ml) for an additional 24 h. 
CAT activity in ceillysates was determined according to the butyryl CoA assay [32[. All 
experiments were carried out at least four times in duplicate with two separate plasmid 
isolations. 
RESULTS 
Organization of the hamster ISG-54K gene. To isolate the hamster ISG-54K gene, 
a human ISG-54K exon 2 specific probe (561 bp EcoRI-EcoRI fragment (22)) was used to 
screen a hamster genomic library in AEMBL3. A positive clone (HG-1 I was selected and 
characterized for BamHI, EcoRI and Hindlll cleavage sites (Figure 1 AI. Exon 2 specific 
sequences could be localized in a 5 kb EcoRI fragment. The direction of this gene segment 
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was determined by sequence analysis following comparison to the human homologue (22). 
The position of exon 1 was mapped utilizing parts of the 3.4 kb Hindlll-EcoRI and the 3.6 
kb Hindlll-Hindill fragments as hybridization probes on Northern blots of RNA isolated from 
MuIFN-a6 treated CHO-12 cells (data not shown). 
The single copy hamster ISG-54K gene is composed of two exons, the intron has 
a size of 3.4 kb and the sequences flanking exon 1 and 2 are according to the consensus 
splice donor/acceptor rules (Figure 1 B). The position of the intron was confirmed by 
sequencing of a eDNA fragment obtained by peR with axon 1 and axon 2 specific primers 
(data not shown). The first exon is very smJII (81 bp). and provides the 5'-untranslated 
region and the first five nucleotides of the open reading frame (ORF). The second exon 
contains the remaining part of the ORF and the 3'-untranslated region. The ORF encodes 
a protein of 468 amino acids. The protein shows no homology to any other known protein 
sequence, except for the human ISG-54K protein (62%). and, to a lesser extend, the 
human ISG-56K protein (38%) [33,34). A putative polyadenylation signal [AATAAA), 
which will give rise to a mRNA of the correct size is present at + 2568. 
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FIGURE 1. IsolaUM and characterization of the hamster ISG-54K gene. fA} Partial restriction map of the 
hamster genomic DNA clone HG·1, containing the ISG·54K gene (B:8amHI. R:EcoRI, H:Hlndlll, P:Pst/, S:Sacl). 
Boxed regions indicate the 2 exons, the closed boxes cOffespond to the open reading frame. The horizontal 
bar represents the 'ragment used for hybrldisat/on probe fEcoRI-SacIJ. 
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Induction of ISG-54K mRNA expression In hamster CHO-12 cells by MuIFN-a6 
treatment. A 1.5 kb EcoRI-Sacl probe (Figure 1 A) was used to monitor the response of the 
hamster ISG-54K gene to IFN-a treatment. Figure 2 shows the Northern blot analysis of 
RNA isolated from IFN-a treated and controi CHO-12 cells. The 2.8 kb ISG-54K mRNA, 
which cannot be detected in the absence of IFN (iane 1; even after overexposure of the 
autoradiograph, data not shown). is highly induced within 4 h (iane 3) and reaches a 
maximum level (at least 40-fold induction) approx. 8 h after IFN incubation (iane 4), The 
mRNA level remains high until at least 48 h postinduction (lane 6). 
1 234 5 6 
ISG-54 
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FIGURE 2. Northern blot analysis of IFN·a Induced ISG-54K mRNA expression in hamster CHO-12 cells. IFN 
treatment (50 IVlml) In CHO-12 cells was for 0,2,4,8,24, and 48 h {lanes 1-6, respectively}. A 1.5 kb 
EcoRi-Sacl fraoment, indicated In Figure fA, was used as a hybridization probe. Hybridization with an actin 
probe was used as an Internal control. 
Mutation analysis of the hamster ISG-54K promoter. The presumed transcription 
start site of the hamster ISG-54K gene is deduced from the corresponding human ISG-54K 
gene (see Figure 1B and ref. 22). A variant TATA box (TATATA) is found at -32. Figure 
3A shows the ISRE consensus sequence AGTTTCNNTTTC(CfT). Comparison of the 
sequence of the hamster ISG-54K promoter with the ISRE consensus revealed the 
presence of two structurally closely related segments, one at -97/-85 and a second one, 
directly upstream of this element at -110/-98 (see Figures 1B and 3A). ISRE-I (-97/-85) 
deviates at only one position (-97) from the consensus sequence; ISRE-II is different at 
position -105 (T instead of a highly conserved C). A similar sequence is present in the 
human ISG-54K promoter (Figure 3A)' although previously only the ISRE-I seqence has 
been recognized as such. In conclusion, structural data suggest that the ISG-54K promoter 
contains two directly adjacent ISREs. 
To test the functional importance of the candidate ISREs, mutations were 
introduced in the -110/-85 region and in flanking sequences, as indicated in Figure 3B. In 
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ISRE 2 ISRE 1 
CONSENSUS ISRE AGTTTCNYTTTCY AGTTTCUYTTTCY 
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FIGURE 3. Functional analysIs of the ISG-54K promoter region. fAJ Structural comparison of the ISHE 
consensus sequence and the hamster and human ISG-54K ISRE regions. Dots Indicate Identical nuc/eotides. 
(N) denotes a random base; (Y) a pyrimidine. (8J Effect of mutation of ISRE and ISRE upstream and 
downstream sequences on the IFN·a inducibility of the hamster ISG-54K promoter. Mutations are Indicated 
below the wildtype sequence. CHO-12 cells were transfected with wifdtype or mutant hamster ISG-54K 
promoter (8amHI- Pst!,· -431 to +31) The activity of pHISG54-1-CAT is taken as 100%. 
each modified ISRE the three highly conserved adjacent T residues were changed, 
generating four different "single" mutations (pHISG54-3-CAT to pHISG54-6-CAT in Figure 
3B, respectivelyl and one "double" mutation (pHISG54-7-CAT). Further mutations were 
made in the regions flanking the ISREs, one 5' (pHISG54-2-CAT in Figure 3Bl. the second 
one 3' to the ISRE region (pHISG54-8-CAT in Figure 3B). All mutated promoters were used 
in transient transfection assays in CHO-12 cells. The activities of the mutated promoters 
were compared with that of the wildtype promoter (pHISG54-1-CATl, which shows a 40-
to SO-fold induction upon IFN treatment. The results of a representative experiment are 
illustrated in Figure 3B_ Mutation of the region downstream of the ISRE segment (TTC to 
GAG at -83/-81 I had no effect on the IFN-a response of the ISG-54K promoter (compare 
the activity of pHISG54-8-CAT and pHISG54-1-CAT). Both mutation of the T triplet at -
95/-93 and that at -89/-87 in ISRE-I caused a strong decrease of IFN-a induced promoter 
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activity, however, the promoter was not completely inactivated. Both pHISG54-5-CAT and 
pHISG54-6-CAT show a residual activity of 3%. This indicates that ISRE-I alone, although 
important, is not enough for maximallSG·54K promoter activity in response to IFN-a. This 
observation is substantiated by the results obtained with pHISG54-3-CAT and pHISG54-4-
CAT, which both disrupt a T-triplet in the ISRE-II region. Interestingly, both mutations 
show a significant decrease in transcriptional response to IFN-a. Activities of 25% and 
20% compared to wild type were found, respectively. A more upstream mutation (at -114/-
112; pHISG54-2-CAT) has no effect on promoter strength. The "double" mutation 
pHISG54-7-CAT, which has two mutated ISREs shows no response at all to IFN-a, 
suggesting that the -110/-85 segment determines completely the responsiveness to IFN-a 
of the ISG-54K promoter. 
Properties of the ISRE region. Sequential substitution of the three ISRE-I bases, 
which differ in ISRE-II, created mutants pHISG54-1 O-CA T, pHISG54-11-CAT and pHISG54-
12-CAT, respectively (Figure 4). 
CONSTRUCTS 
-III ·U 
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pHlSGl54-IO-cAT 
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FIGURE 4. Effect of sequential mutation of the three ISRE-/ nuc/eotides, which differ in/SHE-II, on the IFN-a 
Inducibility of the hamster ISG-54K promoter. Mutations are indicated below the wildtype sequence. CHO-12 
cells were transfected with wildtype or mutant hamster ISG-54K promoter (8amHI- Pst/; -431 to + 31) CA T 
reporter gene constructs as described in Materials and Methods. 
When assayed for promoter activity, pHISG54-10-CAT and pHISG54-12-CAT show an 
activity which is similar to wildtype activity. However, pHISG54-11-CAT has an activity 
of only 20 % as compared to wildtype, which equals the activity of a promoter that 
contains two ISRE-II sequences (pHISG54-9-CAT). This indicates that the T at position -
105 in ISRE-II is responsible for its lower activity. 
71 
The mechanism of ISRE-I and ISRE-II cooperation in ISG-54K promoter activity. 
Comparison of the hamster ISG-54K wildtypepromoter activity (11-1. Figure 5) (100%)' 
containing ISRE-I and ISRE-II, with the activities of a single ISRE-I (I. Figure 5) or ISRE-II 
(II, Figure 5) (22% and 3%, respectively), indicates synergistic cooperation between ISRE-I 
and ISRE-II. The same effect is seen if two copies of ISRE-II are present (II-II, Figure 5). 
Compared to the wildtype promoter, it gives 20% activity. This shows first of all that the 
combination ISRE-I and ISRE-II functions better then two ISRE-lIs, and, secondly, that two 
ISRE-lis are approx. 7 times more active than a single ISRE-II, again pointing to a 
synergistic cooperation. A promoter with two copies of ISRE-I (I-I, Figure 5)' functions 
slightly better (120%) than the wildtype combination (Figure 5; compare 1-1 and II-I, 
respectively)' and approx. 5 times better than a single ISRE-1. So, also in this situation a 
synergistic cooperation between two ISREs is observed. 
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FIGURE 5. The effect of changing the type of ISflE on the IFN-Q inducIbility of the hamster ISG-54K promoter. 
Mutations are Indicated below the wlldtype sequence. CHO-12 cells were tronsfected with wildtype O( mutant 
hamsterlSG-54K promoter (BamHI-Pstl; -431 to + 31 ) CAT reporter gene constructs. The activit yo! pHISG54-
I-CAT Is taken as 100%. 
In the ISG-54K promoter. ISRE-I and ISRE-II are located directly adjacent to each 
other (Figures 1 Band 3A). This led us to investigate the possibility that the synergistic 
action of the two ISREs could require direct sequence alignment. The effect of varying the 
spacial arrangement between the ISREs was tested by insertion of two spacer DNAs of 
different size. Experiments were done with pHISG54-9-CAT, which contains two copies 
otiSRE-II, as a basis construct. A 5 bp (pHISG54-9a-CAT) and a 10 bp (pHISG54-9b-CAT) 
insertion mutation were constructed as indicated (see Figure 6 and Materials and 
Methods). This resulted in the generation of two mutations, in which the two ISREs are 
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FIGURE 6. Effect of spacing between two ISRE lis on IFN·q Inducibility of the hamster ISG-54K promoter. 
CHO-12 cells were transfected with wildtype and mutant hamster ISG·54K promoter (8amHI- Pst!; 431 to 
+31 J CA T reporter gene constructs. The activity of pHISG54-1-CAT (not indicated in the figure} is taken as 
100%. 
separated by a half or a complete helical turn, respectively. If transiently expressed in 
CHO-12 cells in the presence of IFN-a, both pHISG54-9a-CAT and pHISG54-9b-CAT show 
a slight decrease in activity as compared to the basis construct. However, this small 
decrease (approx. 40%) does not correspond with a loss of synergistic cooperation 
between the two ISREs. 
DISCUSSION 
lFN stimulated genes provide an attractive system to examine in which way 
transcription regulation in the cell nucleus is mediated through occupation of a cell surface 
receptor by its polypeptide ligand. IFN stimulated genes respond rapidly to the inductive 
signal with an increase in transcriptional initiation. Sofar, a dozen directly IFN-a/p regulated 
target genes has been isolated. These genes contain in the promoter region a sequence 
closely related to the ISRE consensus sequence AGTTTCNNTTTC(CIT) (see for recent 
reviews 1,2,6]. Although a consensus sequence is established from comparison of target 
gene promoters, surprisingly little is known about the strength of an ISRE as compared to 
its sequence. ISRE structure/function analyses have sofar almost exclusively been limited 
to protein binding studies (7,8). We observed that hamster CHO-12 cells are exceptionally 
well suited for functional analysis of ISRE sequences in transient transfection assays, using 
Mu IFN-a6 as inducer. 
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To study the transcriptional response to IFN-a, we isolated the hamster ISG-54K 
gene. The hamster ISG-54K promoter contains two functional ISREs [lSRE-1 at -97/-85; 
ISRE-II at -110/-98 (Figures 1 Band 3A)1. Previously, ISRE-I has also been identified in the 
human ISG-54K promoter at a similar position 181. The hamster and human ISG-54K 
promoters are highly conserved in the ISRE region. This suggests that the human ISG-54K 
promoter, also contains two ISREs, which are the major control elements of these 
promoters. ISRE-I in the human ISG-54K promoter binds ISGF3 and ISGF2, as shown by 
mutational analysis (8). Functional testing of ISRE-I mutants revealed a slight (50%) 
decrease in promoter activity. 
A detailed analysis of the hamster mutants, as presented in our study, established 
that both ISRE-I and ISRE-II could independently direct IFN-a regulated transcriptional 
response, but ISRE-I has an approx. 7-fold higher activity. The T at position -105 in ISRE-II 
is responsible for the difference in activity between ISRE-I and ISRE-II. The upstream ISRE 
in the human ISG-54K promoter (human ISRE-II) contains a C at a position comparable to 
the T in the hamster ISRE-II (Figure 3A), which could render this ISRE more active than 
ISRE-II in the hamster ISG-54K promoter. 
It is of obvious importance to investigate the role of the different ISRE-binding 
transcription factors in ISG·54K expression. The set of mutants generated in this study 
together with the hamster CHO-12 transfection system, will form an excellent model to 
study in detail the interaction of ISREs with purified ISGF2[1RF-l) 19J, ISGF3 (components) 
134-37J and other factors 110-13, 15J. Co-transfection experiments with expression 
plasmids encoding the various factors and the different ISRE-CAT reporter gene constructs 
will provide further information on their role in IFN mediated regulation of gene expression. 
The synergistic cooperativity of two ISREs did not strictly depend on the 
combination of ISREs, but for maximum activity the ISRE doublet had to contain at least 
one ISRE-I. Variation of the spacial arrangement between two ISRE-lis did not drastically 
affect promoter activity. This points to a mechanism of synergism between two ISREs 
through an indirect interaction between IFN-stimulated transcription factors binding to the 
different ISREs. It can be hypothesized that, upon IFN-a induction, IFN-stimulated 
transcription factors, when bound to the two different ISREs, interact simultaneously with 
the same or different components of the preinitiation complex at the transcriptional start 
site (Figure 7). Therefore, it would be interesting to study the interaction of the different 
IFN~a induced factors with general transcription factors andlor presumed co-activators 
138J. 
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Transcription 
Initiation complex 
FIGURE 7. Schema';cal representation of the Interaction of ISRE-binding transcription factols (lSGFs} with the 
transcription Initiation complex. at the ISG·54K promoter. 
Structural comparison reveals that, in addition to the ISG-54K gene, the related 
I~G-56K gene, and the ISG-15K gene are candidate genes with two adjacent ISREs in the 
promoter region (lSG-56K: AGTTTCACTTTCCCCTTTCGGTTTCC [231: ISG-15K: 
GGCTTCAGTTTCGGTTTCCCTTTCC [39J). ISG-54K, ISG-56K and ISG-15K are not only 
induced by IFN-alp, but also directly by virus and poly[l).poly(C) [23,40,411- This could 
indicate a common mechanism involved in regulation of these specific 9anes. Detailed 
analysis of the ISRE region of these genes further shows striking structural homology to 
the -96/-64 fragment, including the PRDI and PRDIII region, of the IFN-P promoter (-64 
CACTTTCACTTCTCCCTTTCACTTTTCCTAT -96), which is necessary for virus induction 
of the IFN-P gene [9, 42-451. Virus induction of the IFN-P promoter is at least partially 
mediated by ISGF2(IRF-l). Whether it also involves activation of ISGF3 has not been 
c)early established. So, it is possible that in response to viruses or other cytokines (like IL-1 
or TNF) [23,40,45), the ISRE region functions as a PRDl/ililike region. In this situation the 
direct adjacent sequence alignment of the two ISREs could be important to reach 
. maximum induction. Experiments to test this possibility are in progress. 
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SUMMARY 
The interleron-a (lFN-a) regulated mouse ISG-54K/-56K gene family. which Is 
composed 01 at least lour members (lSG-54K. ISG-56K1. K2 and K3), was isolated and 
characterized. In addition, the chromosomal localization of the four genes was determined. 
The ISG-54K and ISG-56K1 genes show an Identical organization. Both are composed 01 
a very small lirst exon and a second exon. which contains the complete open reading 
Irame. except lor the ATG start codon and the lirst two nucleotides 01 the second codon. 
In both genes. the two exons are separated by a small intron (5 kb and 2.5 kb. 
respectively). Expression 01 both genes is rapidly Induced by IFN-a (within 2 h). The ISG-
54K promoter region contains two sequences, which are closely related to the Interferon 
Stimulated response Element (lSRE) consensus sequence (lSRE-I: GGTTTCAATTTCT. and 
ISRE-II: AGTGTTACTTTCT). The two elements are located directly adjacent to each other . 
. A similar organization was recently established for the hamster ISG-54K promoter 
(Bluyssen et al .. 1994)_ However. the mouse promoter is 70% less active than the 
hamster promoter_ It turned out that ISRE-II is hardly active. due to the G at position 4. 
which is a T in the hamster ISG-54K ISRE 2 and in the ISRE consensus sequence. The ISG-
56K1 promoter region contains at a similar position two functional ISREs of identical 
strength (lSRE-I: AGTTTCAGTTTCT. and ISRE-II: AGTTTCACTTTCC)_ In the ISG-56K1 
promoter. the two ISRE motlls are separated by six bp. In addition to the ISG-56K1 gene. 
(parts) 01 two closely related genes (56K2 and 56K3) were isolated. Both fragments 
contain an ISG-56K 1-related open reading frame. However, we were unable to isolate the 
presumed first exon of 56K2 and 56K3. neither could we show expression of the genes. 
sofar_ The ISG-54K. -56K1. -K2 and -K3 genes could all be assigned to the 01 region of 
mouse chromosome 19. suggesting a tight clustering. 
INTRODUCTION 
Type I interlerons (lFN-a/PJ are cytokines that exert many effects on a wide 
variety of target cells. These include the establishment of an antiviral state, inhibition of 
cell growth, and modulation of the immune system (see for reviews De Maeyar and De 
Maeyer-Guignard. 1988; Williams. 1991; Sen and Lengyel. 1992; Stark and Kerr, 1992). 
Type I IFNs interact with a specific cell surface receptor to trigger its biological 
response (Uze et al .. 1990). Recently. the signal transduction mechanism has been 
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elucidated to a large extend. Upon binding of the ligand, the IFN receptor activates at least 
two cytoplasmic tyrosine kinases (JAK1 and Tyk21 (Velazquez et aI., 1992; Muller et al., 
1993; Shuai et al., 1993; Silvenoinnen et al., 19931. This leads to the phosphorylation of 
the structurally related transcription factors STAT p113 and p911p84 (Fu et al., 1992a; 
Fu et aI., 1992b; Schindler et aI., 1992a; Schindler et aI., 1992bl. Together with the p48 
DNA·binding subunit (Levy et aI., 1989) they form the multi protein complex ISGF3, which 
interacts with specific sequences in the DNA (Dale et aI., 1989; Levy et al., 1989; Kessler 
et aI., 1990). This subsequently leads to the induction of expression of a group of cellular 
genes (for review see Pellegrini et aI., 19931; the products of these IFN-stimulated genes 
(lSGsl either singly or coordinately mediate the biological activities of IFNs. 
Functional and structural analyses of the promoter of IFN-alp target genes resulted 
in the identification of a minimal response element needed for IFN-induction {referred to 
as Interferon Stimulated Response Element or ISRE; consensus sequence 
AGTTTCNNTTTCYI (Levy et aI., 1986; Reich et aI., 1987; Cohen et aI., 1988; Porter et 
aI., 1988; Pellegrini and Schindler, 1993). 
Sofar, a dozen IFN'regulated genes have been identified (Pellegrini and Schindler, 
1993). Among these are the human (Larner et aI., 1984; Levy et al., 1986) and hamster 
ISG-54K gene (Bluyssen et aI., 1994). and the human ISG-56K gene (Larner et aI., 1984; 
Wathalst at aI., 1986), which are structurally related, indicating that they are derivatives 
from a common ancestor. The function of these genes is unknown. Both the ISG-54K and 
ISG-56K gene map to human chromosome 10 (10q23'q24) (Lafage et aI., 1992). To be 
able to investigate in more detail the function of the ISG-54K and ISG-56K genes, and 
analyze the regulation of their in vivo expression, we initiated the analysis of the mouse 
homologs. In this study we present the structure, chromosomal localization and regulation 
of expression of the mouse ISG-54K/56K gene family. 
MATERIALS AND METHODS 
Growth of cells and IFN treatment. Cells were maintained in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 5% fetal calf serum (FCS) and antibiotics. The 
supernatant of constitutively mouse IFN producing CHO cells (CHO-12 clone 28, which 
produces MuIFN-a6 was used as the IFN source (van Heuvel et aI., 1988). MuIFN-a6, 
which is active on both hamster and mouse cells (van Heuvel et al., 1986), was purified 
by affinity chromatography over a MuIFN·a specific antibody column. 
For RNA isolation, L929 cells were grown to 50% confluency and for a further 2, 
81 
8 and 24 h in the presence (or continued absence) of MuIFN-a6 (50 IUlml). For 
transfection experiments, CHO cells were seeded at 5 x 105 cells per 6 em dish. After 
overnight transfection, cells were incubated for 24 h in the presence of MuIFN-a6 (50 
IUlml) or in the absence of IFN. 
Isolation of ISG-54KI56K genes from a mouse genomic DNA library. The mouse 
genomic library, in AEMBL3 SP6fT7, was purchased from Clontech !Palo Alto, CAl. The 
library was screened according to standard procedures (Sambrook et aI., 1989). A 1.5 kb 
EcoRI-Sacl fragment, derived from exon 2 of the hamster ISG-54K gene (Bluyssen et aI., 
1994), was used as a hybridization probe in order to screen for the mouse ISG-54K gene. 
To identify phages containing the mouse ISG-56K genes, a 380 bp fragment, obtained by 
amplification on mouse L929 genomic DNA using specific (degenerate) primers (5'-
AGTGATCAGGGGCAACTTTGCTTGG-3' and 5'-
TGTTCGAAGTCCCGTTCCTC(CfT)TG(AIG)AA-3'; see also Figure 2B), was used as a 
hybridization probe. After three rounds of plaque purification, DNA was isolated and 
characterized by restriction mapping and Southern hybridization. 
DNA and RNA analyses. Genomic DNA (20 Jig)' isolated from L929 cells, was 
digested with the proper restriction enzymes and the fragments were separated over a 
0.8% agarose gel. Southern blotting and hybridization were essentially as described 
(Sam brook et ai., 1989). 
Total cellular RNA was isolated by the guanidinium thiocyanate method (Chirgwin 
et a) .. 1979). 20 Jig RNA was denatured by glyoxal treatment, separated by electrop-
horesis on a 1 % 8garose gel and transferred to a nylon membrane (GeneScreen, New 
England Nuclear (NEN), Boston, Mal. using the method described by the supplier. Filters 
were hybridized with DNA probes labelled as described (Feinberg and Vogel stein, 1983). 
Overnight hybridization at 42°C in 50% formamide and washing of the filters were as 
described by NEN and Sam brook et al. (1989). Filters were exposed to Kodak X-Omat AR 
film at -70'C using intensifying screens. 
S l-nuclease-protection assay, RACE and RT -PCR. For the S l-nuclease protection 
assay, a 330 bp EcoRI-Rcal ISG-54K and a 320 bp BamHI-Ncol ISG-56K DNA fragment 
(see Figures 2A and 2B, respectively) were used as a probe. The fragments were end-
labeled with T4 polynucleotide kinase (GibeD BRL, Grand Island, NY), and approx. 100.000 
cpm radiolabelled fragment were annealed overnight at 55'C to 40 ug L929 RNA in 80% 
formamidel40 mM-Pipes (pH 6.5), 0.4 M NaCI, 1 mM EDTA (Favaloro et al .. 1980). Sl-
nuclease (Boehringer, Mannheim. Germany) digestions were carried out for 1 h at 37°C, 
and the resulting protected fragments were separated on a 6% denaturing polyacrylamide 
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gel. 
To obtain ISG-56K exon 1 sequences, we used the RACE (Rapid Amplification of 
cDNA Ends) protocol according to Frohman et al. (1988). Primer 5'-
CTTCTCTTGCTCAGCTGCTCGCT-3' (conserved between ISG-56Kl, -2, and -3) was 
applied to synthesize first strand cDNA on RNA isolated from IFN-a treated mouse L929 
cells. For RT-PCR (reverse-transcriptase - polymerase chain reaction) of ISG-54K2 and ISG-
54K3, primer 5'ATGACAGCCTGGATG-3' (conserved between ISG-56K2 and ISG-56K3) 
was used in combination with the above mentioned RT-primer on L929 cDNA. PCR 
conditions: 30 cycles of 1 min 94'C, 1 min 55'C and 2 min 72'C. 
Sequence analysis of the mouse ISG-54K and ISG-56K genes. Nucleotide 
sequences were determined by the dideoxy chain termination method (Sanger at aI., 
1974), using T7 polymerase (Pharmacia, Uppsala, Sweden). 
Construction of plasmids. All plasmid constructs were prepared according to 
standard methods (Sam brook et al" 1989). The promoterless plasmid pCAT-Basic 
(Promega, Madison, WI) was used as a basis vector to link a ISG-54K or ISG-56K promoter 
fragment to the CAT reporter gene. For pMISG54-1-CAT, an EcoRI-Psti (-2521 + 32) mouse 
ISG-54K promoter fragment, with a blunt ended EcoRI site, was subcloned into pTZ19 
(SmaI/Pstl). The insert was subsequently excised by Hindlll digestion (the Hindlll site was 
blunted with Klenow DNA polymerase), followed by Sacl digestion. Next, the fragment 
was ligated into the Sacl and blunt ended Xbal sites of pCAT-Basic. To construct the 
pMISG56-1-CAT plasmid, a BamHI-Hindlll {-223/+2991 mouse ISG-56Kl promoter 
fragment was subcloned into pGEM7 {BamHI-Hindllll. Using this construct as template 
DNA in PCR, the m13 forward and reverse primers were applied to amplify the ISG-56Kl 
promoter fragment. This PCR product was subsequently digested with Hinfl, blunted, 
followed by Sac I digestion. The fragment was then ligated into pCAT-Basic (Sacl/Xbal 
blunt ended). 
In vitro mutagenesis. Mutations in the ISRE region (-1101-85 in the ISG-54K 
promoter; -100/-69 in the ISG-56Kl promoter) were introduced according to the method 
of Higuchi et al. (1989). Standard conditions were: 30 cycles of denaturation for 1 min at 
95°C, annealing for 2 min at 55 °C, and extension for 2 min at 72°C. Two outer primers 
were used (indicated below by 'at' and 'or', respectively: f =forward, r = reverse) and two, 
overlapping inner primers (denoted by the na'TIe of the corresponding mutant: f = forward 
and r = reverse), with the mutation. The oligonucleotides which were used for generation 
of the different mutants are listed below. Residues in lower case indicate differences from 
the wildtype sequence. 
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ISG-54K: 
of 5' GAGCTCGGTACCGAATTCAG 3' 
or 5' TCAGGAGCTAAGGAAGCTAA 3 ' 
pMISG54-2f 5 ' GTGACATACGTtTTACTTTCTGG 3' 
pMISG54-2r 5' CCAGAAAGTAAaACTGATGTCAC 3' 
ISG-56K: 
of m13 forward primer 
or m13 reverse primer 
pMISGS6-2f 5' CTTCAGTTTCACggaCCAGTCTCAGTTTCA 3' 
pMISG56-2r 5' TGAAACTGAGACTGGtccGTGAAACTGAAG 3' 
pMISG56-3f 5' TTTCACTTTCCAGgacCAGTTTCAGTTTCT 3' 
pMISG56-3r 5' AGAAACTGAAACTGgtCCTGGAAAGTGAAA 3' 
pMISG56-4f 5' TCTCAGTTTCAGgaccTCACTGCTGAC 3' 
pMISG56-4r 5 ' GTCAGCAGTGAGgtcCTGAAACTGAGA 3' 
The amplified ISG-54K fragment was digested with Sacl and Pst!, and subcloned 
into pTZ19 Sacl/Pst!, followed by insertion into pCAT-Basic according to the procedure 
which was described for the construction of pMISG54-1-CAT_ The ISG-5SKl PCR 
products were digested with Hinfl, which was blunt ended with Klenow DNA polymerase, 
and Sacl, following inserting in pCAT-Basic by the procedure which was described for the 
,construction of pMISG5S-1-CAT. The structure of each mutant was confirmed by 
sequencing. 
Transfection procedure and CAT assay. CHO cells were seeded at 5 x 10' cells/S 
em dish, The next day, cells were transfected with the appropriate promoter-CAT reporter 
gene construct (5 Jig) according to the calcium phosphate precipitation method (Chen and 
Okyama, 1987). After overnight incubation with the precipitate, incubation was continued 
in the absence or the presence of MuIFN-aS (50 IU/ml) for an additional 24 h, 
Subsequently cells were harvested, CAT activity in celllysates was determined according 
to the butyryl CoA assay (Seed and Sheen, 1988). All experiments were carried out at 
least four times in duplicate with two different plasmid isolates. In contrast to observations 
in Hela cells (Pine et al., 1988), transfection of CHO cells with the calcium phosphate 
precipitation method did not give rise to high background levels, 
Fluorescent in situ hybridization analysis (FISH). The probes were labeled by 
standard nick translation with biotin-l 6-dUTP (Boehringer Manheim). 50-100 ng probe in 
hybridization mixture (50% formamide, 10% dextransulphate in 2xSSCP) with 5 Jig 
sonicated salm sperm DNA and 5 Jig yeast tRNA, was heat denatured and pre annealed 
with 10Jlg mouse cot-l DNA (Gibco BRl, Gaithersberg USA) for 30-60 min, at 37 'c, The 
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target DNA was also heat denatured (70°C, 2 min.) followed by hybridization overnight 
at 37 °e, After washing, hybridization sites were visualized by immunofluorescence using 
Avidine D-Fitc (Vector, USA). A second round of amplification was usually required. The 
slides were counterstained with propidium iodide and 4' ,6',diamino-2-phenylindole (DAPI) 
in anti fade medium (DABCO). 
RESULTS 
Organization of the mouse ISG-54K and ISG-56K genes. 
To isolate the mouse ISG-54K gene, a hamster ISG-54K exon 2 specific probe (1.5 kb 
Sacl-EcoRI fragment (Bluyssen et aI., 1994)) was used to screen a mouse genomic library 
in AEMBL3. This resulted in the isolation of two overlapping clones (MG-1 and MG-2l. 
which were characterized for Bam HI, EcoRI and Hindlll sites (Fig. 1A). Exon 2 specific 
sequences could be localized on a 2.8 kb EcoRI-EcoRI fragment. The direction of this gene 
segment was determined by sequence analysis, and comparison to the hamster and the 
human ISG-54K gene structures (Levy et aI., 1986; Bluyssen et aI., 1994). By 
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Figure 1. Isolation andchafacleriz8tion of the mouseISG-54KIISG-56K gene family_ fA) Partial restriction map 
of the mouse genomic DNA clones MG-' and -2, MG-a and MG-b and -c, and MG-d and -e, containing the 
ISG-54K and ISG-56KI, -56K2, and -56K3 gene, respectively (B.-BamHI, R:EcoR/, H.-HindI//, K:Kpn/, P.-Pst/, 
S:Sacl). Boxed regions Indicate the 2 exons, the closed boxes cOffespond to the open reading (rame. The 
horizontal bars below the ISG-54k and -56KI genes, represent the (ragment used as hybridization probe 
(EcoR/-Kpnl and peR-amplified (ragment, respectively)_ 
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Southern blot hybridization of phage MG-1 DNA, digested with different enzymes, with a 
hamster ISG-54K exon 1 specific probe, exon 1 of the mouse ISG-54K gene could be 
localized. Southern hybridization of mouse genomic DNA with an ISG-54K 0.9 kb EcoRI-
Kpnl exon 2 specific probe (indicated in Figure 1 A below the ISG-54K genel showed that 
the mouse ISG-54K gene is single-copy (Fig. 1 B) . 
21.2 Kb-
5.1 Kb-
4.3 Kb-
2.0 Kb_ 
1.9 Kb-
1 2 3 
ISG-54K 
1 2 3 
ISG-56K 
-21.2 Kb 
-5.1 Kb 
-4.3 Kb 
__ 2.0 Kb 
{1.9 Kb 
Figure 1. Isolation and characterization of the mouse ISG-54K/ISG-56K gene family. (B) Southern blot of/alysis 
of the ISG-54K and /SG-56K genes In genomic DNA derived from mouse 1929 cells. The DNA was digested 
with BamHI (lane 1), EcoRl (fane 2), and HindI/! (lane 3). For hybridization a mouse ISG-54K 0.9 kb £coRI·Kpnl 
and a 0.4 kb mouse ISG-56K, exon 2 specific probe were used, respectively. 
In order to isolate the mouse ISG-56K gene(s), we first generated a probe by 
emplification of an ISG-56K specific fragment on genomic DNA from mouse L929 cells, 
using degenerate primers (see Material and Methods; indicated in Figure 28). The primer 
sequences were deduced from conserved regions of human ISG-56K gene (Wathelet et aI., 
1986) and hamster (Bluyssen et al" 1994) and human (Levy et aI., 1986) ISG-54K genes. 
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The resulting 0.4 kb exon 2 mouse ISG-56K probe (indicated in Figure 1 A, below the ISG-
56K1 genel, hybridized with three different fragments on a Southern Blot of mouse 
genomic DNA (Figure 1 B), suggesting the existance of at least three different ISG-56K-like 
genes. The probe did not cross-hybridize with the mouse ISG-54K gene. 
By screening a mouse genomic library in AEMBL3, using the 0.4 kb mouse ISG-
56K PCR fragment as a probe, we isolated three different sets of phages (MG-a; MG-b, 
and -c; MG-d, and -e, respectively)' according to the BamHI, EcoRI, and Hindlll restriction 
maps (Figure 1A). ISG-56K exon 2 specific sequences could be localized on a 1 kb EcoRI-
Hindlll fragment in MG-a, on a 2 kb BamHI-BamHI fragment in MG-b, MG-c and on a 0.8 
kb EcoRI-Hindlll fragment in MG-d, MG-e, respectively. The direction of the open reading 
frame in each gene (named ISG-56K1, ISG-56K2 and ISG-56K3, respectively) was 
determined by sequence analysis, and comparison to the human ISG-56K gene structure 
(Wathelet et al., 1986). With the RACE protocol (using a primer which is conserved 
between ISG-56K1, -2, and -3 to make first strand cDNA; indicated in Figure 2B) on RNA 
isolated from IFN-a treated mouse L929 cells, cDNA fragments were isolated, which after 
sequencing all turned out to contain exon 1 sequences of the ISG-56K1 gene. By 
hybridization of such a probe with phage MG-a DNA, digested with different enzymes, 
exon 1 of ISG-56K1 was localized on a 0.5 kb BamHI-Hindlli fragment approx. 5 kb 
upstream of exon 2 (see also Figure 1 A). Hybridization with phage MG-b and MG-d, using 
the 0.5 kb BamHI-Hindlll fragment, however, did not provide a positive fragment. In 
addition, for RT-PCR of ISG-54K2 and ISG-54K3, a conserved primer between ISG-56K2 
and ISG-56K3 was used in combination wiih the above mentioned RT-primer on L929 
eDNA. However, this did not result in identification of axon 1 sequences specific for these 
genes. Trying several other approaches, including restriction enzyme analysis of L929 RT-
PCR cDNA, and screening of another mouse genomic library with an ISG-56KI exon I 
fragment, we were unable to identify ISG-56K2 and ISG-56K3 cDNA and exon 1 
sequences. 
Response of mouse ISG-54K and ISG-56K gene expression to IFN-a. The 0.9 kb 
EcoRI-Hindlll fragment was used as a hybridization probe to monitor the response of the 
mouse ISG-54K gene to IFN-a treatment. Figure 1 C shows the Northern blot analysis of 
RNA isolated from IFN-a treated and control L929 cells, actin mRNA is used as an internal 
control. The ISG-54K mRNA (- 2.8 kb), not present without IFN (lane 1), even after 
overexposure of the autoradiograph (not shown), is highly induced within 2 h (lane 2) 
reaching the maximum level around 8 halter IFN addition (lane 3). The ISG-54K mRNA 
concentration remains high until at least 24 h postinduction (lane 4). 
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To determine the mouse ISG-56K1 mRNA expression pattern, following IFN 
induction in L929 celis (Figure 1 C), a similar experiment was done (using the 0.4 kb PCR 
amplified fragment as a probe). The mouse ISG-56K1 messenger (-1.9 Kb) is present at 
a very low basal level in untreated L929 cells (lane 1), significant induction already occurs 
after 2 h of IFN treatment (lane 2). Maximum level is reached after 8 h of incubation (lane 
3); expression remains high for at least 24 h (lane 4). 
1 2 3 4 1 2 3 4 
ISG-54K 
••• I • ISG-56K 
ACTIN •••• ,. ACTIN 
IFN-a (h) o 2 8 24 o 2 8 24 
Figure t.lsolation and characterization of the mouse ISG-54KI/SG-56K gene family. fe) Northern blot analysis 
of IFN-a induced ISG-54K and ISG-56Kl mRNA expression in mouse £929 cells. IFN treatment (50 /U/mIJ In 
£929 cells was for D. 2, 8, and 24h (fanes 1-4, respectively). The same probes as in (8) were used for 
hybridization. An actin probe was used as an internal control. 
Analysis of the mouse ISG-54K and ISG-56K1 gene: nucleotide and predicted 
amino acid sequence. The ISG-54K and ISG-56K1 genes show an identical organization 
(Figures 1 and 2). In both genes, the open reading frame is separated over two exons. The 
intron, of which the position was confirmed by PCR on cDNA using exon 1 and exon 2 
specific primers (data not shown!. has a size of 2.5 and 5 kb, respectively. In both genes, 
the first axon provides 5'-untranslated sequences and the first five nucleotides of the open 
reading frame. The second exon contains the remaining part of the open reading frame and 
3'-untranslated sequences. The ISG-54K open reading frame encodes a protein of 473 
amino acids; the ISG-56K1 open reading frame encodes 464 amino acids. The proteins are 
structurally related (40% homologous). Both proteins are very hydrophilic, rich in polar 
(28.5 % and 30 %, respectively) and charged (31.7% and 29.5%, respectively) amino 
acid residues. The search for sequence homology in data bases did not result in detection 
of any related gene, except for the human ISG-54K and ISG-56K genes (see also Levy et 
al" 1986; Wathelet et al" 1986; Wathelet et al" 1988al. 
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Figure 2. Structural analysis of the mouse ISG·54K gene and ISG-56KI gene. (AJ Nucleotide sequence of the 
mouse ISG·54K gene. The transcription start site is indicated as + 1. The EcoRI-Sca/ fragment was used as 
a probe for S 1 analysis. The ISRE motifs in the promoter are underlined. The amino acid sequence of the IS6· 
54K protein, as deduced flom the open reading frame is presented below the nucleotide sequence. 
89 
:!3l ~;m~!~~r~~rn: -l~ :3g:!:::!!::::!~::!1 79 t~" 
103 
146 
191 
236 
281 
326 
371 
416 
461 
506 
551 
596 
641 
686 
731 
776 
821 
866 
'11 
956 
1001 
1046 
1091 
1136 
1181 
1226 
1271 
1316 
1361 
1406 
1451 
!i!§ 
1670 
........ 
Figure 2. Structural analysis of the mouse ISG-54K gMe and ISG-56Kf gene. fB} Nucleotide sequence of the 
mouse ISG-56Kl gene. The transcription start site is Indicated as + 1. The BamHI-Ncol fragment was used 
as a probe for SI analysIs. The ISRE motifs In the promoter are underlined. The amino acId sequence of the 
ISG-56KI protein, as deduced from the open reading frame Is presented befow the nucleotide sequence. 
Primers used for constructfon of the peR probe f5'·AGTGATCAGGGGCAACTTTGCTTGG-3' and 5'-
TGTTCGAAGTCCCGTTCCTC{CfflTG{AlGIAA-3'1 and for RACE protocol {5'-CTTCTCTTGCTCAGCTGCTCGCT-
3'J (see also Materials and Methods) are underlined. 
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Determination of the transcription start sites of the mouse ISG-54K and -56K 1 
genes. In order to identify the transcription initiation site(s) of the mouse ISG-54K and ISG-
56K1 genes, an S1 nuclease protection experiment was performed on RNA isolated from 
L929 cells, which were treated with IFN for 8 h. RNA from untreated cells was used as 
a control. Hybridizing probes were chosen in the region spanning the longest cDNA 
fragments, and deduced from the known structure of the human ISG-54K and ISG-56K 
genes (Levy et al" 1986; Wathelet et al" 1986). The results of the experiments are 
depicted in Figure 3. In case of the ISG·54K gene, protected fragments (lane 2), mapped 
in a region between 77 and 82 bp upstream of the ATG translation start codon (see also 
Figure 2A). 
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Figure 3. Determination of the Iranscr/ption initiation sites of the mouse ISG-54K gene and ISG-56KI gene by 
SI nuclease mappIng. A 330 bp EcoRl-RsaIISG-54K and a 320 bp BamHI-NcoIISG-56KI probe were usedi 
respectively (see also Figures 2A and 8/. Lane!, L929 RNA (untreated); lane 2, L929 RNA (treated for 8h with 
IFN-aJ. The end points of the major protected fragments ate indicated with an asterisks alongside a sequence 
contaInIng part of the ISG-54K and ISG-56Kl promoter respectively. 
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The most prominent signal (+ 1 in Figure 2A) co-located with the position of the 
transcription initiation site as defined in the human ISG-54K gene (Levy et al., 1986). RNA 
from untreated cells did not give protected fragments (lane 1), indicating again that ISG-
54K mRNA is not expressed in cells grown in the absence of IFN. 
For the ISG-56K1 gene, protected fragments were identified, which map in a 
region between 95 and 98 bp upstream of the ATG (see also Figure 2B). The most 
prominent signal was found at a T, 97 bp upstream of the ATG (+ 1 in Figure 2B). 
Chromosomal localization of the ·mouse ISG-54KIISG-56K gene family. To 
determine the chromosomal localization of the mouse ISG-54K and ISG-56K genes, FISH 
on metaphase chromosome spreads of two different mouse leukemia cell lines (RED-8 and 
RMB-2) was performed (see Material and Methods). The biotinylated genomic clones MG-1 
and MG-2, MG-a, MG-c, and MG-e (see Figure 1 A), were used as probes for ISG-54K, ISG-
56K 1, ISG-56K2, and ISG-56K3, respectively. 
Figure 4. Chromosomal localization of the mouse ISG-54K gene by in situ hybridization, (A) Metaphase from 
Red-8 cel/line hybridized with the ISG-54K gene (plobe MG-21, demonstrating signals on chromosome 19 and 
19q+ (indicated by an arrow). R-banding was done with propidium iodide after Brdu IncorpolatiOflin lale-S 
phase. (8) Partial metaphase of Red-8 cells with clear signals 0/1 chromosome 19 and 19Q+ using probe MG-2. 
92 
Eleven to 45 meta phases were analyzed for the different probes. The results of 
representative experiments are shown in Figures 4 and 5. Metaphases from the Red-S cell 
line (Figure 4A and Bl. hybridized with probe MG-2 (lSG-54K), clearly demonstrated signals 
on chromosome 19 and 19q + (Figure 4). 
Figure 5. Chromosoma//ocalization of the mouse ISG-56K genes by In situ hybridization. Partial metaphase 
of mouse leukemia cell line RMB-2, hybridized with probes for different ISG-56K genes. (A) Probe for the ISG-
56K1 gene (MG-a) maps on both chromosomes 19 (indicated by an arrow) and in one thIrd of the cells on an 
unidentified marker chromosome that presumably contains chromosome 19 sequences (indicated by an 
asterisk). (A') DAPI staInIng 01 the same metaphase as (A). (B) Hybridization with the ISG-56K2 gene probe 
(MG~), clearly labeling both chromosomes 19. (B', DAPI stain/ng of the same metaphase as (B). ICl/(D) 
Hybridization with the ISG-56K3 gene probe (MG-e), showing clear signals on both chromosome 19 and in one 
third of the cells (D) on the proximal part of a large chromosome. (e') DAPI staining of the same metaphase 
as lei. 
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On the RM8-2 cell line (data not shown) signals on both chromosomes 19 were seen. 
Using MG-1 (only done on REO-S cells), appart from signals on 19 an 19q+ an additional 
signal was seen (in 100% of the cells) on the proximal part of a large chromosome (data 
not shown). Metaphases from RMB-2 cell line, hybridized with MG-a (lSG-56K1l. MG-c (-
56K2) or MG-e (-56K3) showed in all cases signals on both chromosomes 19 and in one 
third of the cells on the proximal part of un unidentified marker chromosome (Figures 5A, 
B, C and D). Using metaphase spreads from Red-S cells, Mg-a, MG-c and MG-e all 
hybridized with chromosome 19 and 19q +. MG-e (-56K3) showed in one third of these 
cells an additional signal, located on the same large chromosome as seen after MG-1 
hybridization (data not shown). In conclusion, consistent hybridization signals for all probes 
used were only obtained with chromosome 19. 
Structural and functional analysis of the mouse ISG-54K and ISG-56K1 gene 
promoter. Previously, we showed that the hamster ISG-54K promoter contains two 
adjacent, functional ISREs (lSRE-1 and ISRE-II) of different strength, which act 
synergistically for maximallFN-a inducibility (8luyssen et al" 1994). The mouse ISG-54K 
promoter is structurally closely related to that of the corresponding hamster gene, and the 
mouse ISG-54K ISRE-region shows a comparable organization (indicated with ISRE-II and 
ISRE-I) (Figures 2A and 6A). However, using a -290 to +31 mouse ISG-54K promoter-
CAT reporter construct in a transient transfection assay I a consistently lower activity as 
compared to the hamster wildtype promoter (approx. 30%) was observed 
(shown in Figure 6A, denoted with pMISG54-1-CA T and pHISG54-1-CAT, respectively). 
Structural analysis of the mouse ISG-54K ISRE-region 
(AGTGTTACTTTCTGGTTTCAA TTTCT), shows that it is completely identical to that of the 
hamster promoter (AGTTTT ACTTTCTGGTTTCAATTTCTl. except for a G at position 4 in 
the presumed ISRE-II sequence, instead of a T in the hamster promoter at this position 
(Figure 6A). To test whether the G in the mouse ISG-54K ISRE-II was responsible for the 
lower activity, a G to T substitution was introduced at this position, thereby creating 
mutant pMISG54-2-CAT (Figure 6A). II translected in CHO cells this mutant has the same 
maximum promoter activity in the presence of IFN as the hamster wildtype promoter 
(pHISG54-1-CAT) (Figure 6A). 
Structural analysis 01 the mouse ISG-56K 1 promoter shows the presence 01 two 
segments, which completely lit with he ISRE consensus sequence AGTTTCNNTTTCY 
(lSRE-II: AGTTTCACTTTCC, and ISRE-I: AGTTTCAGTTTCT in Figures 28 and 6B). 
However, in contrast to the ISG-54K ISREs, the ISG-56K1 ISRE motils are not adjacent, 
but separated by 6 bp. To test the functional importance of ISRE-II, ISRE-I, and the 
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Figure 6. Characterization of the mouse ISG-54K and ISG-56K 1 promoter. fA) Interferon-(/ inducibility of wild 
type and mutant mouse ISG-54K promoter CA T constructs. Mutations are indicated below the wildtype 
sequence. CHO ceffs were transfected with promoter CA T reporler gene constructs as described in Materials 
and Methods. Afler trans/ection, ceffs were grown with IFN (50 /U/ml; 24 h) or without IFN. Quantilation of 
CA T activity was achieved as described in the Malerials and Methods section. The activity of pHISG54-f-CA T 
Is taken as 100%. (B) Interferon-a inducibility of wild type and mutant mouse ISG-56Kf promoter CAT 
constructs. For details see (A and Materials and Methods). The actlvlty of pMISG56-I-CAT Is taken as 100%. 
intervening sequence, several mutations were introduced into the mouse ISG-56K1 
promoter as indicated (see Figure 68). In this way three different "single" mutants 
(denoted pMISG56-2-CAT to pMISG56-4-CAT in Figure 6B) and one "double" mutant 
(pMISG56-5-CAT) were constructed. Each of these mutants was used in transient 
transfection assays in CHO cells and compared with the wildtype ISG-56Kl promoter 
(pMISG56-1-CAT). The results of a representative experiment are shown in Figure 6B. 
Single ISRE·II mutation or single ISRE·I mutation caused a decrease of IFN-a induced 
promoter activity of about 70%, as compared to that of the wildtype promoter (Figure 6B). 
This indicates that both ISREs are equally. important for maximal ISG·56K promoter 
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activity. Mutation of the sequence between ISRE-II and ISRE-II (pMISG56-3-CAT) had no 
effect on promoter activity. The "double" mutant pMISG56-5-CAT, with a mutation of 
both ISRE sequences, shows no response at all to IFN-a, indicating that ISRE-II and ISRE-I 
of the mouse ISG~56K1 promoter are essential for maximal response to IFN. 
DISCUSSION 
In order to be able to study the function of the ISG-54K and ISG-56K genes, and 
to investigate in vitro and in vivo regulation of expression, we isolated the mouse ISG-
54K/ISG-56K gene family. The sequences of the complete ISG-54K and ISG-56K1 genes 
are closely related, especially in the first half of the open reading frame. This is in 
agreement with the structural homology between the human ISG-54K and ISG-56K 
proteins (Levy et aI., 1986; Wathelet et al" 1986; Wathelet et al" 1988a). The expression 
in response to IFN-a showed a similar pattern (Figure 1 C). Previously, we showed that the 
hamster ISG-54K promoter contains two adjacent, functionallSREs (ISRE-I and ISRE-II) of 
different strength, which act synergistically for maximallFN-a inducibility (Bluyssen et al., 
1994). We postulated an identical mechanism for the human ISG-54K and the human ISG-
56K promoter, which show a similar structural organization of two adjacent candidate 
ISREs (Bluyssen et al., 1994). The mouse ISG-54K promoter showed a structural ISRE 
organization (lSRE-II: AGTGTTACTTTCT and ISRE-I: GGTTTCAATTTCT, adjacently 
located) which was almost identical to that of the hamster ISG-54K promoter (Bluyssen 
et al" 1994). However, the mouse ISG-54K promoter was 70% less active than the 
hamster promoter, which was caused by the G at position 4 in ISRE-II. To determine 
whether this G was mouse strain specific or not, we amplified and sequenced the 
corresponding fragment from different mouse sources (P919, NIH/Swiss, BALB/c, C57BI). 
In all DNA preparations a G was found in ISRE-II instead of a T (data not shown), so, the 
mouse ISG-54K promoter contains one strong ISRE (lSRE-1) and a related sequence (lSRE-
11), which is not or hardly active. This is in contrast to the human (Wathelet et al" 1988b), 
monkey (Bluyssen, to be published) and hamster (Bluyssen et al" 1994) ISRE-II. Because 
of the synergistic interaction, even the weak ISRE-II in the hamster promoter is of 
importance for high induction levels. 
The mouse ISG-56K1 promoter contains two functional ISRE motifs (lSRE-II: 
AGTTTCACTTTCC, and ISRE-I: AGTTTCAGTTTCT; Figure 6A). Both ISREs are needed for 
maximum activity upon IFN-a treatment. Individually they show a similar activity (30-40 
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% of the wild type promoter). Compared to the ISRE consensus (AGTTTCNNTTTCY), ISRE-
II and ISRE-I of the mouse ISG-56Kl promoter are "perfect" ISREs. In contrast to the 
human ISG-56K promoter, the ISREs are not localized adjacently, but separated by 6 bp. 
Although not tested in this study, it is to be expected that the 6 bp distance hardly affects 
promoter strength (compare the studies on the hamster ISG·54K promoter (Bluyssen et al" 
1994)]. Although less clear than in the hamster ISG-54K promoter (Bluyssen et aI., 1994), 
functional studies again point to a mechanism of cooperativity between two ISREs through 
transcription factors binding to the two motifs. 
Additional to the ISG-54K and ISG·56Kl gene, we identified two other mouse 
ISG56K genes (lSG-56K2, and ISG-56K3). The genes are structurally closely related to 
each other and also to ISG-56Kl exon 2 sequences. Although a long open reading frame 
and a perfect splice acceptor site were found (Figure 7 and data not shown), we were 
unable to locate the presumed exon 1 of ISG-56K2 and ISG-56K3, indicating the possibility 
that we are dealing with two pseudogenes. The finding that we were unable sofar to 
identify transcripts from ISG-56K2 and ISG-56K3 supports this hypothesis. The occurrence 
of human ISG-56K pseudogenes has also been suggested (Wathelet et al" 1988; Lafage 
et al" 1992). On the other hand it is very well possible that the 56K2 and 56K3 regions 
both are part of a larger, functional gene from which the more upstream'9xon(s) remains 
to be isolated. If there is such an axon, its structure must deviate considerably from ISG-
56Kl exon 1. It would be of high interest to further investigate different tissues for ISG-
56K2 and ISG-56K3 expression. However, because the promoter region is unknown, their 
regulated expression might be completely different from that of ISG-56Kl (and ISG-54K). 
In Figure 7 a comparison is presented between the deduced amino acid sequences 
of the mouse ISG·56Kl, ISG-56K2 and ISG·56K3, and ISG-54K genes. Especially the N-
terminal half of the various proteins is highly conserved. All cysteine residues in this region 
in ISG-56Kl (seven) are present in 56K2 and 56K3; five of them can also be found in ISG-
54K, a sixth overall conserved cysteine is present at position 290. This suggests that the 
different polypeptides can adopt a similar secundary and tertiary structure, and might have 
a common biological function. It can be speculated that well conserved motifs are of high 
importance for this function. Unfortunately, the amino acid sequences do not provide a 
clue in this respect. 
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Figure 7. Homology between the predicted amino acid sequences of the mouse ISG·56K, and ISG·54K genes. 
Conserved Cystelnes are Indicated by arrow heads, homology is Indicated by dots; stripes indicate deletions. 
Asterisks indicate the deduced end·polnts. The ISG·56K2/·K3 conserved primer, used for race protocol (5'-
A TGACAGCCTGGATG·3'), Is underlined in the -56K2 sequence. 
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The ISG-54K gene and ISG-56K1, -56K2 and -56K3 genes are all assigned to the 
01 region of chromosome 19. Although no overlapping genomic fragments were found, 
this strongly suggests that the four genes are tightly clustered. 
The structural homology indicates that the genes arose through duplications of a 
common ancestral gene (named X in Fig. 8). On the basis of the structural homology an 
"evolutionary pedigree", as shown in Figure 8, can be proposed. Because the homology 
is much higher between ISG-56K1 and ISG-56K2 and -56K3 64 and 62%, respectively) 
than between ISG-54K and ISG-56K1, -56K2, and -56K3 sequences (40% in all cases), 
it can be suggested that the first gene duplication reSUlted in ISG-54K and a common ISG-
56K1,2,3 ancestor (lSG-56K in Figure 8). As a next duplication, the evolution of a ISG-
56K2,3 precursor gene (lSG-56K-1A in Figure 8) and ISG-56K1 can be proposed. This ISG-
56K1A gene may not have contained ISG-56K1-like exon 1 sequences. The most recent 
duplication event could result in the generation of ISG-56K2 and -56K3, which are highly 
homologous to each other (80%). 
54K [ill 
56K-l 
[IQQJ 
x 
56K 
56K-1A 
~ 
56K-2 56K-3 
[EJ m:J 
Figure 8. Evolutionary origin of the mouse ISG-54KIISG-56K gene family (X ancestral gene). Numbers In the 
open boxes represent homology with ISG-56KI. 
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In the human genome, the ISG-54K gene and the ISG-56K gene have been 
assigned to chromosome 10 at bands q23-q24 ILafage et aI., 1992). Presumed 
pseudogenes were found at chromosome 10 and 13 (Wathelet et al" 1988a; Lafage et aI., 
1992). Our assignment of the mouse ISG-54K/56K genes to chromosome 1901 is in good 
agreement with the human·mouse comparitive gene map (Davisson et ai., 1991; Lyon and 
Kirby, 1993). Human chromosome 10q homologous loci are present on mouse 
chromosome 14 and 19. However, most loci on human 10q23-q24 (RBp4, ONTT and 
others) have their corresponding mouse homolog on mouse chromosome 1901. 
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CHAPTER 5 
I~N-y INDUCTION OF THE ISG-54K PROMOTER THROUGH ISRE 
SEQUENCES; ROLE OF P48(1SGF3y) AND P91(1SGF3a) BUT NOT 
P113(1SGF3a) 
Hans A.R. Bluyssen', Remko J. Vlietstra', Angellque C.J. van der Made', Jan 
Trapman', and David E. Levy2. 'Department of Pathology, Erasmus University, 
Rotterdam, The Netherlands, 2Department of Pathology, New York University 
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Submitted for publication. 
103 
SUMMARY 
Interferon stimulated gene-54K (lSG-54K) gene expression was found to be 
Interferon-y (lFN-y) regulated In Vera cells, which lack the IFN-aIP genes_ This IFN-y 
Induction was shown to be mediated through the interferon stimulated response element 
(lSRE) sequence. Co·transfection of Vero cells with expression vectors for the 48-
kllodalton Interferon stimulated gene factor3 (lSGF3) protein (p48), the 91-kilodalton 
(lSGF3) protein (p91) and the 113-kilodalton ISGF3 protein (p113) in the presence of IFN-
y, showed a role of p48 and p91, but not p113 in ISG-54K promoter activation In the IFN-y 
response pathway. In contrast. IFN-a stimulation was maximal in the presence of all three 
factors. The results obtained implicate that, in addition to the IFN-Y activated sequence 
(GAS) mediated pathway, IFN-y can regulate gene expression via activation of p48, p91 
and a proposed third factor, which interact in an ISGF3-lIke complex with the ISRE 
sequence. Our findings could explain the overlapping set of genes regulated by both IFN-
alp and IFN-y. 
INTRODUCTION 
Interferons (lFNs) can induce an antiviral state in target cells. In addition, IFNs are 
known to affect many other cell functions including cellular differentiation, growth and the 
immune response. IFN-alp (Type IIFNs) and IFN-y (Type IIIFN) interact with cells through 
distinct receptors (1). Receptor-specific ligand binding in either case rapidly induces 
tyrosine phosphorylation of latent cytoplasmic transcription factors (2). 
Transcription factors active in the IFN-alp signal transduction pathway have been 
extensively documented. Most important, IFN-alp binding leads to phosphorylation on 
tyrosine of the structurally related 113K (pI13) and 91 K (p91) (or the alternatively spliced 
84K (p84)] components of the a-subunit of ISGF3 (interferon-stimulated gene factor 3) 
. (3.4). Subsequently, activated ISGF3atogether with the 48K (p48) DNA-binding v-subunit 
(5), join in the multi protein complex ISGF3 and migrate to the nucleus (6). Here the ISGF3 
complex binds to the interferon-stimulated response element (lSRE) sequence in the 
regulatory region of target genes, to initiate transcription (6,7). The two related 
cytoplasmic protein tyrosine kinases TYK2 and JAK 1 have been shown to be essential in 
the IFN-alp signal transduction pathway (8-10). 
104 
Although it has recently drawn much attention, the IFN-y signal transduction 
pathway is less well understood. Interestingly, IFN-y can activate a set of genes, which 
is partially overlapping with the IFN-alp target genes (1). Recently, it has been shown that 
the 91 kDa component of the a subunit of ISGF3 (p91) is phosphorylated on the same 
tyrosine (Tyr 701) in response to IFN-y as in response to IFN-alp (11,12). Activated p91 
translocates to the nucleus, where it binds to the GAS (gamma activating sequence) 
element to initiate transcription of target genes (2,13). The protein tyrosine kinases JAKl 
and JAK2 are involved in the IFN-y signal transduction pathway (9,10,14). 
Safar, the mechanism of overlapping IFN·alp and IFN-y target gene expression is 
only partly resolved (both involve JAKl and p91). Using the interferon-stimulated gene-
54K (lSG-54K) gene as a model, we provide evidence that the ISRE sequence can not only 
be a target for IFN-alp activated transcription factors, but also for IFN-y activated factors. 
Both p4B and p91, but not pl13 are important for IFN-y induced initiation of ISG-54K 
transcription. We presume, that in case of IFN-y, in addition to p48 and p91, a third factor 
is involved in optimal activation of the ISG-54K promoter through the ISRE sequence. 
RESULTS AND DISCUSSION 
Figure 1 A shows a Northern blot analysis of RNA isolated from IFN-a and IFN-y 
treated (for 24 h) and control Vera cells, hybridized with an ISG-54K specific probe (15). 
Both IFN-a (lane 2) and IFN-y (lane 3) are able to induce ISG-54K mRNA expression. 
Because Vera cells lack IFN-alp genes (16), the IFN-y induction is not indirect via IFN-alp. 
Previously, it was assumed that ISG-54K induction was IFN-a specific (17). Our data show 
that, at least in Vera cells, and in a HeLa cell subline grown in Rotterdam (data not 
shown), ISG-54K expression can also be induced by IFN-y. 
A 1 2 3 
ISG-54K 
ACTIN 
Fig 1. Regulation of the monkey ISG-54K gene. rAJ Northern blot analysIs of IFN-a and IFN-r-Induced ISG-54K 
mRNA expressIon in monkey Vero cells. /FN treatment (500 IUlml) In Vero celts was for 24 h (lane 1, no 
treatment/lane 2, IFN-o; lane 3, IFN-yJ, A 561 bp EcoRl fragment (15J, was used as a hybridization probe. 
Hybridization with an actin probe was used as an internal control. 
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To study thelFN-yregulation of the1SG-54K promoter in more detail, the monkey ISG-54K 
promoter was isolated (181, and the sequence was determined (Fig. 181. The promoter is 
highly homologous to the previously isolated human and hamster counterparts (17,191. 
Two identical, adjacent ISRE sequences (AGTTTCACTTTCTI are present in the -88 to -113 
region. To find out whether the monkey ISG-54K promoter was able to respond directly 
to IFNs, it was cloned in lIont of the CAT reporter gene (18) (pAISG54-1-CATI. Lysates 
prepared from transiently tranfected Vero celis, with or without IFN-a or IFN-y treatment, 
.were assayed for CAT activity (201 (Fig. 1 CI. A response to both IFN-a and IFN-y is seen. 
The relative responses are in good agreement with the levels of mRNA induction of the 
endogenous gene (Fig. 1 AI. So, the promoter fragment used, containing the double ISRE 
region, is sufficient to confer inducibility to each type of IFN. 
(8) 
-388 
-338 
-288 
-238 
-188 
-138 
-88 
-38 
(C) 
CCTTAGCAGGAAGTGGGCTTTGCTATTCTGTGTATATCTTTAACAATACC 
TGCTGAAAAGAACCCTTTTGTTAAATAATTGTATTACGAGTGCCCAACTT 
AGTCCTTTCGAATATGAGATAAGAGAGGGACCGTGCACAAGAGCAATGCC 
CCCAGACACATCTTGAAGTGAAGCACGGGGCGAATGAAACATCCCTCTCT 
GCTGCCTTCTTTCTCTGATACGCCTCTGATTCCCGAGGAAAAAGAGTGCT 
+1 
AGTTGTGTATATAGGTCTTTTCAGCGTTTATTGGTGGCAGAAGAGGAA 
3 
CAT aotlvity (DPM xl0 ) 
30 
26 
20 
15 
10 
5 
_ -Inducer 
_ + IFN-alpha 
D + IFN-gamma 
o LI""'-"-_~ __ 
pAISG54-1-CAT 
Fig 1. Regulation of the monkey ISG·54K gene. (8) Nucleotide sequence of the monkey ISG-54K promoter. 
The presumed transcription start site Is Indicated as + 1. The duplicated ISRE sequence and a variant TA TA· 
box are underlined. (e) IFN·q and IFN·y·inducibility of the monkey ISG-54K promoter. Vera cells were 
transfected with a monkey ISG-54K promoter·CA T reporter gene construct (18). CAT-activity (OPM x 1(11) in 
cells treated with IFN·q and IFN-y was compared to that from untreated cells. 
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Previously, we generated a large series of mutants in the ISRE region of the 
hamster ISG-54K promoter, in order to establish the role of the two ISRE sequences in IFN-
a induction in hamster CHO celis (19). Our data showed that the two ISREs are both 
necessary and sufficient for maximum activation of the ISG-54K gene upon IFN·a 
treatment. To study a presumed role of the double ISRE sequence in relation to IFN-y, a 
set of hamster (wild type and mutant) ISG-54K promoter CAT constructs was used in 
transient transfection assays in Vero celis (201. For IFN-a and IFN-y, an identical induction 
pattern emerged (Fig. 2). Mutations in the regions flanking the ISREs had no effect on 
promoter activity (pHISG54-2-CAT and pHISG54·S-CAT); mutation of the T triplet at -95/-
93 and that at -S9/-S7 in ISRE-I caused a strong decrease of both IFN·a and IFN-y induced 
promoter activity (pHISG54-5-CAT and pHISG54-6-CAT); mutants pHISG54-3-CAT and 
pHISG54-4·CAT, which both disrupt a T-triplet in the ISRE-il region (-10S/-106 and -102/-
100, respectively), showed a partial decrease in activity in response to IFN·a or IFN·y. 
Importantly, the "double" mutation (pHISG54-7-CAT) completely knocked out IFN'a and 
IFN-y inducibility. Constructs containing two ISRE-Is (pHISG54·1/I-CAT in Fig. 2) or two 
ISRE-ils (pHISG54-il/il-CAT in Fig. 2), show a similar IFN'a and IFN-y induction. Together, 
these results point not only to an essential role of the ISRE sequences in IFN·y activation, 
but also to a similar mechanism of IFN-y and IFN-a induction. involving identical or similar 
transcription factors. 
pHISOe4-1-CAT 
pHlsoe4-2·CAT 
pHISGts4-3-CAT 
pHISGe4-4-CAT 
pHlsoe4-6-CAT 
pHlsae4-6-CAT 
pHlsae4-7-CAT 
pHlsoe4-8-CAT 
pH1SGe4-l1/1l-CAT 
pHISM4-lJl-CAT 
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FIg. 2. Effect of mutation of ISRE I and ISRE If and ISRf upstream and downstream sequences on IFN-<J and 
IFN-y Inducibility of the hamster ISG-54K promoter. Mutations are Indicated befow the wildtype sequence. Vero 
cells were transfected with wi/dtype or mutant hamster ISG-54K promoter (BamHI· Pstl; -431 to + 31 J CA T 
reporter gene constructs as described (19,20J. CAT-activity (DPM x 101) in cells treated with IFN-a and IFN-y 
was compared to that from untreated ceffs. 
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Using the ISG-15K ISRE region as a model system, the ISGF3 complex has shown 
to be the transcriptional activator that mediates IFN-a-induced activation (6,21). To 
investigate the role of this complex in relation to ISG-54K activation upon IFN-a treatment, 
electrophoresis mobility shift assays (EMSA) were performed (22). Unfortunately, for 
unknown reasons, the ISG-54K ISRE region (even a mutant with two strong ISREs) 
provides much weaker in vitro protein-DNA interactions than the ISG-15K ISRE region. 
Therefore, we were unable to obtain reproducible band shifts with IFN-y sensitive Vera and 
Hela cell extracts (data not shown). Figure 3 show results obtained with extracts from 
IFN-a treated hamster CHO cells and the ISG-15K and ISG-54K ISRE regions, respectively 
(22; there is no IFN-y, which is active on CHO cells). ISGF3, which cannot be detected in 
extracts of untreated cells (lane 1 L is induced within 2 h (lane 2) and reaches a maximum 
level approximately 5 h after IFN-a treatment (lane 3). The ISGF3 level remains high until 
at least 24 h postinduction (lane 4), which correlates with the kinetics of appearence of 
the ISG-15K and ISG-54K messenger (19,23) in IFN-a treated CHO-1 2 cells. These data, 
combined with the transfection experiments presented in Fig. 2 make it very likely that 
ISGF3 or ISGF3-like complexes are involved in IFN-a and IFN-y activation of the ISG-54K 
promoter. 
IFN-a(h) 
02 524 
.......... 
.d 
ISG-15K 
IFN-a(h) 
02 524 
.. , . 
la 
ISG-54K 
Fig. 3. ISGF3 DNA-binding activity In response to IFN-a treatment. CHO cells were untreated or treated with 
IFN-a (as indicated) before detergent lysis and analysis of extracts by gel band shift with labeled 
oligonucleotide (22). Cytoplasmic extracts (5 PO) were added to DNA binding reactions containing an ISG-15K 
/SHE oligonucleotide or an ISG·54K ISHE oligonucleotlde (22J, respectively. 
To study in more detail the role of I~GF3 constituents (pl13, p91, and p48) in 
relation to IFN-a- and IFN-y-induced activation of the ISG-54K promoter, co-transfection 
experiments were performed in Vero cells, using the hamster ISG-54K wild type promoter-
CAT construct (pHISG54-1-CAT in Fig. 4) and different combinations of expression 
plasmids containing cDNAs of the various ISGF3 transcription factors (p48, p91, ,1113; 
p84 was not investigated) (24). A representative experiment is shown in Figure 4. In the 
absence of IFN, overexpression of two factors increased measurable basal activity of the 
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Fig. 4. Effect of co-transfection of different ISGF3-components on ISG·54K IFN-a and IFN-y induction. Veto 
cells were transfecled with a wildlype hamster ISG-54K promoter-CA T reporter gene constructs (pHI J alone 
or together with expression plasmids, direct/ng the synthesis of p48, p91, and p113 (24), as indicated. CAT· 
act/vlty (DPM x 101) In cells treated with IFN-a and IFN-y was compared to that from untreated cells. 
ISG-54K promoter, possibly due to a low level of phosphorylation by endogenous 
JAK1/JAK2fTYK2. In the presence of IFN-a, any combination of two overexpressed 
factors highly increases ISG-54K promoter activity. We presume that the two 
overexpressed factors form complexes with the endogenous third component, which is 
present at a lower level. As expected, maximal activity is observed when all three 
components of the ISGF3 complex (p48, p91. pl13) are overexpressed. In contrast, in 
none of the (co)transfection experiments, overexpressed p 113 affected ISG-54K promoter 
induction in the presence of IFN-y, extend,ing the observation that p 113 cannot be 
activated in the IFN-y pathway (11,12). However, separate p48 or p91 overexpression in 
the presence of IFN-y increases promoter activity in Vero cells; p48/p91 cotransfection 
provides an even higher activation of the ISG-54K promoter. Interestingly I this maximum 
level is lower than that of IFN-a induction in the presence of p48/p911pl13. Our data 
show that, in addition to p91 important in the IFN-y pathway via binding to the GAS as 
has been we" documented (2,11-131. there is a second IFN-y response pathway, which 
includes p91 , and also p48. We presume that p48 and p91 can bind as a complex to the 
ISRE sequence. Our results presented here for the ISG-54K promoter, were also found to 
be true for the ISG-56K promoter (data not shown), and might be extended to other 
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promoters which contain ISRE sequences, and which can be induced by both IFN-a and 
IFN-y. 
Although we cannot completely exclude the possibility that p48 and p91 are 
sufficient for optimal activation of the ISG-54K promoter in the presence of IFN-y, we find 
it more likely that a third, so far unidentified factor is involved. Several data support this 
hypothesis. (i) In the co-transfection experiments we observed that maximal activity in the 
presence of IFN-y was lower than in the presence of IFN·a (Fig. 4). This is in contrast with 
the expression level of the endogenous gene (Fig. 1 A) and the activity of the ISG-54K 
promoter, without overexpression of the ISGF3 components (Fig. 1 C, 2 and 4). (ii) In some 
cell lines the ISG-54K gene can be activated by IFN-a, but not by IFN·y (earlier reported 
Hela cells (16); and 2fTGH cells, in which the ISG-54K (data not shown) and the highly 
. homologous ISG-56K promoter (25) have been tested). If the p48/p91 complex, which can 
be formed in these cells because IFN-a is active, is sufficient for activation, IFN-y would 
also be able to do so. (iii) The observation that in mutant cell lines, which lack p91(p84) 
and contain p48 and p113 (25), IFN·a induction is knocked out, strongly suggests that a 
complex of at least three factors is needed in the IFN-a pathway (4,11,25). Because the 
same ISRE element can be involved in the IFN-y pathway and because the mutations in the 
ISREs has such a similar ·effect in both IFN-a and IFN-y pathways (Fig. 2), it would be 
surprising if two of the three components, which are also involved in the IFN-o pathway 
would be sufficient for IFN·y·induced activation. 
In Fig. 5 we propose an extension of the original Darnell model of IFN regulated 
gene expression (11). The IFN-y response pathway can be split into two directions: one 
via the GAS element and a second route, which is via the ISRE. The GAS element binds 
p91 and possibly a different (lFN-y specific) member of the p91/p113 family; the ISRE 
binds the ISGF3 complex, containing p48/p91/p113, in case of IFN-a activation and an 
ISGF3-like complex, consisting of p48/p91 plus a third component (X)' in case of IFN-y 
activation. It is a higly attractive hypothesis to presume that this third component is a 
novel (lFN-y specific) member of the p113/p91 gene family, which mayor may not be 
identical to p91-like components binding to the GAS element. While JAK1 most certainly 
is the enzyme that phosphorylates Tyr 701 in p91 (10), component X may therefore be 
a specific substrate for JAK2. The model, as presented here, could cover the observation 
of regulation by IFN-alp and IFN-y of partially overlapping sets of genes. 
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Fig. 5. Pathways of signa/transduction and transcriptional activation in cells treated with IFN-a or IFN-y. 
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CONCLUDING REMARKS 
IFN stimulated genes provide an attractive system to examine in which way 
transcription regulation in the cell nucleus is mediated through occupation of a cell surface 
receptor by its polypeptide ligand. In addition, because of the wide variety of biological 
effects of IFNs it is interesting to identify the function of IFN-regulated genes. Sofar, a 
dozen directly IFN'uIP regulated target genes have been identified (reviewed by Pellegrini 
and Schindler, 1993). All these genes respond rapidly to the inductive signal with an 
increase in transcriptional initiation. In the promoter region they contain at least one 
sequence closely related to the ISRE consensus sequence AGTTTCNNTTTC(CfT). 
In this thesis, studies on the regula lion of expression of the IFN-stimulated ISG-
54K/ISG-56K gene family are reported. The hamster ISG-54K gene and the mouse ISG-54K 
and ISG-56K1 genes were characterized. The genes are identically organized: two exons 
interrupted by one intron (varying from 2.5 to 5 kb in length). The first exon is very small 
(80-90 bpi and only provides the initiating ATG codon of the open reading frame. The 
transcriptional response of the genes to IFN-alp is shows a comparable pattern and is very 
rapid. In addition to the mouse ISG·56K1 gene, (parts oil two closely related genes (lSG-
56K2 and -56K3) were isolated. Both fragments contain an ISG-56K1-related open reading 
frame. However, as yet we were unable to isolate the presumed first axon of -56K2 and -
56K3, and neither could we detect expression of the genes. 
6.1.1 Function of the 54K/56K proteins 
The structure of the hamster and mouse ISG·54K and ISG-56K polypeptides is 
quite similar (Chapter 3 and 41. especially in the amino-terminal half of the molecules (50 
% homology at the amino acid level). This is also true for the human ISG-54K and the 
related ISG-56K protein (see Chapter 1.2.1). The structural similarity suggests that they 
might have a comparable biological activity. Concerning the function of these proteins no 
direct clues have been found. Indirect evidence points to a role in the growth inhibitory 
pathway of IFNs (van Heuvel et aI., 1988), as well as in the antiviral effects of IFNs 
(Wathelet et al" 1988b). To obtain better insight in the physiological role of ISG-54K and 
ISG·56K, several experimental approaches can be proposed. A first approach would be to 
study the cellular and tissue localization of the proteins. In a first attempt to do so (in 
coolaboration with Dr. Boersma (MBLfTNO, Rijswijk) rabbit polyclonal antibodies against 
three ISG-54K peptides with predicted immunogenic potential and specificity were 
developed. Two out of three antisera obtained recognized an ISG-54K bacterial read 
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through product containing the peptide sequence. These antisera were used in Western 
blotting and immunocytochemical experiments on COS cells transiently transfected with 
a mouse ISG-54K eukaryotic expression vector. On this material specific immuno reactivity 
was not obtained. however (data not shown!. 
Several possibilities might be considered to further elucidate the functions of the 
ISG-54K and -56K proteins. First of all. it would be of interest to construct cell lines. which 
produce the ISG-54K or ISG-56K protein constitutively or in a regulated fashion. and to 
monitor the growth rate and resistance to v.iral infection of these cell lines. 
To investigate general ISG-54K and ISG-56K1 function in vivo. it can be 
considered to generate knock-out mouse strains by homologous recombination. If we 
asume that the ISG-56K2 and -56K3 are pseudogenes. two different situations can occur. 
(i) ISG-54K and ISG-56K1 have a similar function and expression pattern. implying that a 
double knock-out mouse would be necessary to result in a phenotype. (ii) ISG-54K and 
ISG-56K1 have a different function or expression pattern. implying that single knock-out 
mice might be informative. Because the ISG-54K/56K genes constitute only one set of a 
multitude of IFN-regulated genes. it is quite well possible that the reulting phenotype will 
not be abnormal. In that case, crossing with mouse strains, in which other IFN-regulated 
genes are inactivated, might provide additional answers. 
The situation would be even more complex if ISG-56K2 and 56K3 are both 
functionally identical to ISG-54K and ISG-56K1. Because it will be impossible to generate 
mice in which all four genes are inactivated, an in vivo approach would only be feasable 
if ISG-56K2 and ISG-56K3 have an expression pattern which is completely different from 
that of ISG-54K and ISG-56K1 (which is not impossible). 
6.1.2 Cooperativlty between two ISREs 
In the promoters of the ISG-54K and ISG-56K genes. approximately 100 bp 
upstream of the transcriptional start site. two ISRE sequences can be found (iSRE-1 and 
ISRE-II). In Figure 1 the ISRE consensus sequence and the ISRE regions of the ISG-
54KIISG-56K genes from different species. as presently known. are compared (Chapters 
3. 4 and 5: Bluyssen et al .• 1994; Bluyssen. unpublished). In all species examined. the 
organization is similar, although there are small differences. Mutation analysis of the 
hamster ISG-54K (Chapter 3) and mouse ISG-56K1 (Chapter 4) promoters. indicates that 
the two ISREs can function separately when induced by IFN-a. however. for a maximal 
response both elements are necessary. The monkey and human ISG-54K/56K promoter 
both contain two strong ISREs. as is the case for the mouse ISG-56K1 promoter. 
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rSRE-II ISRE-I 
CONSENSUS rSRE AGTTTCNNTTTCY AGTTTCNNTTTCY 
ISG-54K HA -110 AGTTTTACTTTCT -98 -97 GGTTTCAATTTCT -85 
ISG-54K MU -110 AGTGTTACTTTCT -98 -97 GGTTTCAATTTCT -85 
ISG-54K HU -112 AATTTCACTTTCT -100 -99 AGTTTCACTTTCC -87 
ISG-54K MO -113 AGTTTCACTTTCT -101 -100 AGTTTCACTTTCT -88 
ISG-56K1 MU -103 AGTTTCACTTTCC -91 -84 AGTTTCAGTTTCT -72 
ISG-56K HU -117 AGTTTCACTTTCC -105 -104 CCTTTCGGTTTCC -92 
ISG-56K MO -117 ACTTTCACTTTCT -105 -104 CGTTTCGGTTTCC -92 
Figure 1. Structural comparison of the ISRE consensus sequence with the ISRE regions of the ISG-54K/ISG56K 
genes from different species. HA, Hamster; HlJ. Human; MO, Monkey; MU, Murine. (N) denotes a random 
base; (Y) a pyrimidine. 
However, the hamster ISG-54K ISRE-II is weak. The structure of the mouse ISG-54K ISRE 
region differs at only one position from that of the hamster homolog, which results in an 
(almost) completely inactive ISRE-II. Nevertheless, the mouse ISG-54K gene is still highly 
inducible with IFN (Chapter 4). This indicates that, in order to obtain physiologically 
relevant ISG-54K levels, one (strong) ISRE can be sufficient. 
When we increased the spacing between the two ISREs in the hamster ISG-54K 
promoter to 5 to 10 bp only a small effect on the cooperativity between the two elements 
was observed (Chapter 3). This finding indicates that the 6 bp distance between the ISREs 
in the mouse ISG-56K1 promoter is of minor importance. To complete these studies, it 
would be of interest to increase the distance between the ISREs even further, and then 
investigate the effect on promoter activity. Furthermore, inserting fragments of different 
length between the two ISREs and the transcription start site might indicate whether or 
not the ISREs indeed need to be positioned in the proximal promoter region, as almost 
without Bxception is observed in IFN-regulated genes. Safar, this subject has not been 
studied in detail. In a pilot study we observed that insertion of a 750 bp fragment in the 
hamster ISG-54K wt promoter, downstream of the ISREs resulted in its almost complete 
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inactivation (Bluyssen, unpublished). 
6.1.3 IFN·qlP·regulated DNA·blndlng factors 
Many proteins interact with ISRE·like sequences (Chapter 1). Some of these 
factors (like IRF·1) stimulate transcription, whereas others inhibit or do not affect at all the 
transcription rate of ISRE-containing promoters. For the ISGF3 complex an increasing 
amount of evidence is provided that it mediates the IFN-a-induced expression of target 
genes (Kessler et al., 1988; Levy et al., 1989). Several recently performed experiments 
support this point. In CHO cells ISGF3 was found to be activated within 2 h, reaching a 
maximum level approx. 5 h after IFN·q treatment and remaining high for at least 24 h 
(Chapter 5). In contrast, in one of the used He La cell strain, although rapid activation 
occurred, ISGF3 was no longer present 8 h after initiation of IFN·q treatment (Levy et al., 
1988; data not shown!. Remarkably, in both cell types ISGF3 presence correlated exactly 
with the kinetics of appearance of the ISG·54K messenger (Chapter 3 and Larner et aI., 
1984). Because safar only for the ISGF3 complex such a correlation was observed, it is 
even possible that ISGF3 might be the sale factor in IFN·qIP regulation of ISGs. 
It seems likely, that in case of one functional ISRE the same factors are involved 
as in the case of two cooperating ISREs, but this needs to be further substantiated. 
Therefore, it is of importance to study in more detail the role of different ISRE·binding 
transcription factors in ISG-54K/ISG-56K expression upon IFN-a treatment. However I a 
drawback of the ISG·54KIISG·56K system is that it is very difficult to show ISRE·protein 
interactions in standard in vitro bandshift assays (Chapter 5, and data not shown). The 
ISG·15K ISRE (AGTTTCGGTTTCC)' on the contrary, has a very high affinity for these 
factors (Chapter 5, and data not shown). By changing the two central nucleotides, AA (in 
hamster ISG·54K ISRE·I) to GG (as in the ISG·15K ISRE), which are supposedly of minor 
importance for ISRE activity, the stability of the in vitro protein·DNA complexes was 
increased. Although not optimal, this seems to be the only possibility to find out more 
about the proteins interacting with ISG·54K/56K ISRE sequences. 
Numerous recent publications clearly show that ISGF3 activity can be regulated 
by specific protein tyrosine kinases (Tyk2, JAK1) (Velazquez et aI., 1992; Muller et ai., 
1993; Shuai et al., 1993b; Silvennoinen et aI., 1993b). Much less is known about protein 
tyrosine phosphatases, which obviously must be involved in the inactivation of the ISGF3 
complex. The prolonged expression of the active ISGF3 complex in CHO cells indicates 
that important tyrosine phosphatases, which are able to inactivate the complex, are lacking 
in these cells. Therefore, the CHO system would serve as an excelent model to study 
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these specific phosphatases. cDNAs encoding phosphatases can be transfected into CHD 
cells and, in co-transfection experiments, their effect on ISG-54K promoter activity can be 
monitored. 
6.1.4 Cross-talk between IFN-a/D and IFN-v slgnaltransduction pathways 
In Chapter 5 we studied the role of the ISRE sequences in IFN-y regulation of the 
ISG-54K gene. Evidence was presented, showing that the ISRE sequence is not only a 
target for IFN-alp activated transcription factors. In case of IFN-y activation, we proposed 
that an ISGF3-like complex binds to the ISRE, containing p48, p9l and a third component 
X (possibly a novel, IFN-y specific member of the pl13/p91 gene family). To obtain more 
evidence for the IFN-y induced, ISRE-mediated pathway, a system has to be developed in 
which binding of this IFN-y-specific complex to the ISRE and/or gene activating via the 
complex can be monitored. 
For binding studies, either the ISG-54K/ISG-56K system has to be optimized, as 
discussed above, or ISRE sequences of other genes, which are similarly activated by IFN-y 
have to be identified. In this respect, studying the role of IFN-y on ISG-15K expression 
might be a possibility. Another candidate gene would be the IP-lO gene. An IFN-y-inducible 
IP-lO unidentified ISRE binding complex, which involves activation of preexisting cellular 
factor(s) (Ohmori and Hamilton, 1993). can be detected as early as 30 min after IFN-y 
treatment. Eventually, factor X has to be isolated, which will enable analysis of its precise 
role. 
An alternative approach to identify "factor X" would be to isolate cDNAs which 
encode proteins structurally related to the p84/p91!pl13 gene family. It is expected that 
this family is larger than the two members identified safar. If new cDNAs become 
available, their expression can be tested in cell lines responsive to IFN-y via the ISRE. In 
addition, they can be used in co·transfection studies, similarly as presented here in Chapter 
5. 
We have not as yet studied the role of p84 in the IFN-y-induced ISRE-mediated 
pathway. Although phosphorylated by IFN-y, p84 is not involved in the IFN-y signal 
transduction pathway via the GAS element (Shuai et aI., 1993a). However, p84 might play 
a role in the IFN-y-ISRE signalling route. In the model proposed, a prerequisite would be 
that it can interact with factor X and take over the function of p91. 
Further complexity of the functional overlap between IFN-alp and IFN-y regulated 
genes comes from evidence that GAS elements cannot only be used in genes inducible by 
IFN-y, but also in genes induced by IFN-a (Khan et al" 1993). Therefore, in Figure 2 we 
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propose a further extension of the model of IFN-regulated gene expression we presented 
in Chapter 5. Assembly of activated p91 (or p84) and pl13 (lFN'a-specific) into the 
ISGF3a component after IFN-a treatment, allows association with ISGF3y (p48), which 
directs the complex to the ISRE. In case of IFN-Y activation of the ISRE route, activated 
p91 (or possibly p84) assembles with X (lFN-y-specific, possibly pl13'related), allowing 
subsequent association with p48. In this way the complex is directed to the ISRE. 
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Figure 2. Pathways of signal transduction and transcriptional activatiun In cells treated with IFN-oIP or IFN-y. 
In IFN-y as well as in IFN·alp·treated cells, activated p91 can bind directly to the 
GAS (Shuai et aI., 1992; Khan et aI., 1993). Similar to the ISRE binding complexes, 
additional specificity-determining subunits are thought to be present in these GAS-binding 
complexes (Fu and Zhang, 1993; Larner et al" 1993; Ruff-Jamison et al" 1993; Sadowski 
et aI., 1993; Silvennoinen etal., 1993a). This model supports the idea that a specificity-
determining subunit combined with a common p91 subunit directs the complex to the 
appropiate target genes. Identification of these specificity-determining subunits, which 
could belong to the same family, should shed more light on the more and more complex 
IFN signal transduction pathways. 
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SUMMARY 
IFNs mediate a wide variety of effects on target cells. Therefore, they are an 
interesting system to study the mechanisms of action of cytokines. Chapter 2 describes 
the molecular characterization of a cluster of four Ha IFN·a genes (Ha IFNa·A 1, -A2, -A3 
and -A4), which are all located on a 30 kb genomic segment. This IFN-a gene cluster could 
be assigned to hamster chromosome 2q, indicating that the Ha IFN-a genas, like the Hu 
and MuIFN-a gene family, are tightly linked in the genome. The Ha IFNa·A 1 and -A3 genes 
both contain proper open reading frames (OR F), encoding proteins of 190 and 189 amino 
acids (including a signal peptide of 23 amino acids), respectively. Aland A3 showed 90% 
homology in this region. The IFNa·A2 and -A4 genes both showed reading frames 
interrupted by stop codons, which would result in the synthesis of truncated IFN proteins. 
Structural comparison of Ha·A 1 and A3, Mu and Hu IFN-a proteins, indicated conservation 
of essential domains. The same was true for the promoter region of the gene, involved in 
the virus inducible expression (virus responsive element or VRE; a 46 bp fragment 
extending from -109 to -64 relative to the cap site) of IFN-a genes. However, the VRE 
sequence suggests that the A 1 and A3 genes are expressed at a low level. Transient 
expression of the Ha IFN-a A 1 and -A3 genes in COS cells showed that both genes gave 
rise to protein products with antiviral properties on hamster CHO cells. In addition, A 1 
revealed high antiviral activity on mouse L929 cells. 
To study the transcriptional response to IFN·a, the IFN-a regulated ISG-54K/ISG-
56K gene family was characterized. In Chapter 3 the hamster ISG-54K gene (which is 
activated in hamster CHO-12 cells by IFN-a at least 40-fold) was isolated and the promoter 
region was characterized in detail. Sequence analysis revealed the presence of two motifs, 
closely related to the Interferon Stimulated Response Element (lSRE) consensus sequence 
. [AGTTTCNNTTTC(CIT)). The putative ISRE-I sequence (GGTTTCAATTTCT) is located at 
position -97 to -85; ISRE-II (AGTTTTACTTTCT)' which differs at three positions from ISRE-
I, is found directly upstream of ISRE-I at position -110 to -98. In a transient transfection 
assay in CHO cells it was shown that both the -971-85 (lSRE-1) and the -1101-98 (lSRE-1Il 
segment were needed for optimallFN induction of the ISG-54K promoter. ISRE-I is seven· 
fold more active than ISRE-II; ISRE-I and ISRE·II act synergistically for maximal IFN-
inducibility. The mechanism of synergism is most probably an indirect interaction between 
transcription factors binding to the ISREs. because an increase in the spacial arrangement 
of the two ISREs did not result in a substantial decrease of promoter activity. 
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In Chapter 4 the mouse ISG-54K/-56K gene family, which is composed of at least 
four members (lSG-54K, ISG-56Kl, -56K2 and -56K3), was isolated and characterized_ 
The ISG-54K and ISG-56K1 genes show a similar organization_ Both are composed of a 
very small first Bxon and a second exon, which contains the complete open reading frame, 
except for the ATG start codon and the first two nucleotides of the second codon_ In both 
genes, the two exons are separated by a small intron (2_5 kb and 5 kb, respectively). The 
ISG-54K open reading frame encodes a protein of 473 amino acids; the ISG-56K1 open 
reading frame encodes 464 amino acids_ The proteins are structuraly related (40%), 
however a possible function until now is unknown_ Expression of both genes is rapidly 
induced by IFN-a (within 2 h). The mouse ISG-54K promoter region shows a similar ISRE 
organization as compared to the hamster ISG-54K promoter (lSRE-I; GGTTTCAATTTCT, 
and ISRE-II: AGTGTTACTTTCT)_ However, the mouse promoter is 70% less active than 
the hamster promoter_ It turned out that ISRE-II is hardly active, due to the G at position 
4, which is a T in the hamster ISG-54K ISRE-II and in the ISRE consensus sequence_ The 
ISG-56K1 promoter region contains at a similar position two functionallSREs of identical 
strength (lSRE-I: AGTTTCAGTTTCT, and ISRE-II: AGTTTCACTTTCC)_ In the ISG-56K1 
promoter, the two ISRE sequences are separated by six bp_ In addition to the ISG-56K1 
gene, (parts) of two closely related genes (K2 and K3) were isolated_ Both isolated 
fragments contain an ISG-56K1-related open reading frame. However, we were unable to 
isolate the presumed first axon of K2 and K3, neither could we show expression of the 
genes, sofar_ Together, the ISG-54, 56Kl, K2 and K3 genes could all be assigned to the 
D1 region of mouse chromosome 19, suggesting a tight clustering_ 
In Chapter 5 the ISG-54K gene expression was shown to be IFN-y regulated_ This 
IFN-y induction was found to be mediated through the ISRE sequence_ Co-transfection of 
Vero cells with expression vectors for the 48-kDa interferon stimulated gene factor3 
(lSGF3) protein (p48). the 91-kDa (lSGF3) protein (p91) and the 113-kDa ISGF3 protein 
(p113) in the presence of IFN-y, showed a role of p48 and p91, but not p113 in ISG-54K 
promoter activation in the IFN-y response pathway. In contrast. IFN-a stimulation was 
maximal in the presence of all three factors_ The results obtained implicate that, in addition 
to the IFN-y activated sequence (GAS) mediated pathway, IFN-y can regulate gene 
expression via activation of p48, p91 and a proposed third factor, which interact in an 
ISGF3-like complex with the ISRE sequence_ Our findings could explain the mechanism of 
regulation of expression of overlapping set of genes by IFN-alp and IFN-y_ 
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SAMENVATTING 
Intaractia van IFN met de eel resulteert in een breed scala van biologische 
effecten. Om die red en is IFN een geschikt systeem voor het bestuderen van het 
werkingsmechanisme van cytokines in het algemeen. Hooldstuk 2 beschrijlt de molekulaire 
karakterisering van een kluster van vier hamster IFN-a genen (Ha IFNa-A 1, -A2, -A3 en -
A4), gezamelijk gelegen op een genomisch segment ter grootte van 30 kilobasen. Dit 
cluster van IFN-a genen kon gelocaliseerd worden op hamster chromosoom 2q. Dit houdt 
in dat, net als de humane en muize IFN-a genen, de hamster IFN-a genen dicht bij elkaar 
liggen in het genoom. De Ha IFNa-A 1 en -A3 genen bevatten beiden een volledig open 
leasraam, respectievelijk koderend va or een eiwit van 190 en 189 aminozuren teen 
signaalpeptide van 23 aminozuren meegerekend). A 1 en A3 vert on en 90% homologie in 
dit gebied. De IFNa-A2 en -A4 genen bevatten beiden een open leesraam dat onderbroken 
wordt door stopkodons, wat de synthase van getrunceerde IFN eiwitten tot gevo!g heeft. 
Uit de structure Ie vergelijking van Ha -A 1 en A3 met mulze en humane IFN-a eiwitten, 
blijkt dat essentiele domeinen geconserveerd zijn. Ditzelfde geldt voor het bij de virus-
geinduceerde expressie betrokken deel van de IFN-a promoter (virus responsief element of 
VRE; een 46 baseparen Iragment gelegen op positie -109 tot -64 ten opzichte van de 
transcriptie start site). Structureel gezien doet de VRE van -A 1 en -A3 echter vermoeden 
dat beida genen laag tot expressie komen. Kortdurende expressie van de hamster -A 1 en-
A3 genen in COS cellen liet verder zien dat deze beide genen eiwitten kunnen produceren 
met antivirale activiteiten op hamster CHO cellen. Daarnaast bleek het ~A 1 eiwit ook aen 
hoge antivirale activiteit te hebben op muize L929 callen. 
Om de door IFN-a-geinduceerde gen transcriptie te kunnen bestuderen werd de 
door IFN-a-gereguleerde ISG-54K/ISG-56K genfamilie geisoleerd en gekarakteriseerd. In 
Hooldstuk 3 wordt de isolatie van het hamster ISG-54K gen (dat in hamster CHO-12 
cellen, behandeld met IFN-a, tenminste 40-maal geactiveerd wordtl en een gedetaileerde 
karakterizatie van de promoter van dit gen beschreven. Structuuranalyse onthulde de 
aanwezigheid van twes motieven, die sterk lijken op de consensus sekwentie van het 
Interferon-gestimuleerde Responsieve Element (lSRE; AGTTTCNNTTTC(CfT)]' De 
vermeende ISRE-I (GGTTTCAATTTCT) sekwentie ligt in het gebied van -97 to -85; direct 
aansluitend, van -110 tot -98, is de ISRE-II (AGTTTTACTTTCT) sekwentie gelegen. Deze 
wijkt op drie posities al van ISRE-1. Met behulp van een kortdurende expressie methode 
in CHO cellen werd aangetoond dat zowel het -97/-85 (ISRE-I) als het -110/-98 (lSRE-II) 
124 
segment noodzakelijk zijn voor optimale IFN inductie van de hamster ISG-54K promoter. 
ISRE-I is daarbij 7-maal actiever dan ISRE-II; ISRE-I en ISRE-II werken synergistisch voor 
een maximale inductie door IFN. Omdat een vergroting in afstand tussen de twee ISRE 
segmenten niet leidde tot aen substantiale daling van de activiteit van de promoter I omvat 
het mechanisme van synergisme hoogstwaarschijnlijk aen indirecte interactie tussen 
transcriptiefactoren die binden aan be ide ISRE elementen. 
In Hoofdstuk 4 wordt de isolatie en karakterisering van de muize ISG-54K/ISG-56K 
genfamilie beschreven. Deze familie bestaant uit tenminste vier leden (lSG-54K, ISG-56Kl, 
-56K2 en -56K3). De ISG-54K en ISG-56Kl genen vertonen een vergelijkbare opbouw. 
Beiden bastaan uit aen klein serste exon en aen tweeds axon, dat vrijwel het gehele open 
leasraam bevat Cop het ATG startkodon en de serste 2 nucleotiden van het tweeds kadan 
na). De axonen worden gescheiden door aen klein intron (respektievelijk 2.5 en 5 kilobasan 
groat). Het ISG-54K open leesraam kodeert voor een eiwit van 473 aminozuren; het ISG-
56K1 open leasraam kodeert voor aen eiwit van 464 aminozuren. Beide eiwitten zijn 
structureel verwant (40%), hun functie eehter is onbekend. De expressie van beida genen 
wordt snal geinduceerd door IFN-a (binnen 2 uur). De muize ISG-54K promoter vertoont 
een ISRE opbouw die vergelijkbaar is met die van de hamster ISG-54K promoter (lSRE-I: 
GGTTTCAATTTCT, en ISRE-II: AGTGTTACTTTCT). De muize promoter is echter 70% 
minder actief dan de hamster promoter. Het bleek dat ISRE-II vrijwel niet actief was, als 
gevolg van de G op positie 4. Op deze plaats is in zowel de hamster ISG-54K ISRE-II als 
in de ISRE consensus sekwentie een T aanwezig. Het ISG-56Kl promoter gebied bevat 
twee functionele ISRE segmenten (lSRE-I: AGTTTCAGTTTCT, en ISRE-II: 
AGTTTCACTTTCC) van gelijke sterkte, op een overeenkomstige positie als in de ISG-54K 
promoter. In de ISG-56K 1 promoter zijn echter de twee ISRE elementen gescheiden van 
elkaar door zes baseparen. Naast het ISG-56Kl gen zijn tevens (delen van) twee verwante 
genen (lSG-56K2 en -56K3) geisoleerd. De beide geisoleerde fragmenten bevatten een aan 
ISG-56K1 verwant open leesraam. Tot nu toe waren we eehter niet in staat om het 
vermeende eerste exon te isoleren van -56K2 en -56K3, evenmin konden we expressie van 
de genen aantonen. De ISG-54K, ISG-56Kl, -56K2 en -56K3 genen konden allen 
geloealiseerd worden op muize chromosoom 1901. Oit suggereert dat ze geclusterd 
voorkomen op het genoom. 
In Hoofdstuk 5 wordt beschreven dat de expressie van ISG-54K gereguleerd wordt 
door IFN-y. Va or deze inductie door IFN-y bleek de ISRE sekwentie van belang te zijn. Co-
transfectie van Vero cellen met expressievectoren voor het 48-kiloDalton (kDa) interferon 
gestimuleerde gen factor 3 (lSGF3) eiwit (p48), het 91-kDa (lSGF3) eiwit (p91) en het 
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113-kDa (ISGF3) eiwit (p113) in aanwezigheid van IFN-y, liet een duidelijke rol voor p48 
en p91, maar niet voor p113, zien in de activiteit van de ISG-54K promoter in de IFN-y 
signaaltransductie route. V~~r maximale stimulatie door IFN~a was de aanwezigheid van 
ane drie de factoren noodzakelijk. Deze resultaten suggereren dat naast de route die 
gebruik maakt van de IFN~y geactiveerde sekwentie (GAS)' er een tweede route is waarin 
IFN-y gen expressie kan reguleren via activatie van p48, p91 en een vermeende derde 
factor, die als een ISGF3-achtig complex bind en aan de ISRE. Onze bevindingen kunnen 
het mechanisme van regulatie van overlappende genen door IFN-alp en IFN-y verklaren. 
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